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Summary
Nuclear eukaryotic genomic DNA is organized in a structure called chromatin, which is
composed of a fundamental unit, the nucleosome. The nucleosome is a protein-DNA com-
plex consisting of a histone octamer core with 145-147 basepairs of DNA wrapped around
it.
Here, I report the 4.8 A˚ resolution cryo-electron microscopy reconstruction of the single-
subunit full-length S. cerevisiae chromatin remodeller Chd1 in complex with a X. laevis nu-
cleosome core particle in the presence of the transition state mimicking adduct ADP·BeF3.
The nucleosome was formed with Widom 601 nucleosomal DNA and 63 bp of extranucleo-
somal DNA. This is the first high-resolution structure of a full-length chromatin remodeller
bound to the nucleosome. The structure reveals an altered nucleosome where two helical
turns of DNA are peeled away from the histone octamer. The cryo-EM structure eluci-
dates the mechanism of Chd1 regulation by the regulatory double chromodomain of the
chromatin remodeller to control efficient chromatin remodelling. The structure allows for a
model describing the molecular mechanism of the Chd1 ATPase motor, where ATP binding
leads to closure of the ATPase motor and translocation of DNA in one base pair steps.
ATP hydrolysis and dissociation of ADP resets the ATPase motor to allow for a new round
of the enzymatic cycle. Chd1 is a 3’-5’ DNA translocase that shifts DNA towards the oc-
tamer dyad, resulting in centering of the nucleosome. My structure provides the foundation
for understanding the mechanism of chromatin remodelling. The gained insights extend
beyond Chd1 to other CHD family members, providing a framework to interpret other
chromatin remodellers.
In addition, I report the crystal structure of a S. cerevisiae RNA polymerase II elon-
gation complex with the modified base 3d-Napht-A in the +1 site. The crystal structure
was solved at a resolution of 3.2 A˚ allowing unambiguous placement of 3d-Napht-A. The
structure revealed that the modified base impairs closure of the trigger loop and prevents
translocation, blocking further elongation. The structure provides the molecular basis for
understanding the effects of minor groove DNA alkylations on transcription and provides
a platform for the targeted design of drugs to impair transcription for therapeutic benefit.
In conclusion, my studies provide an initial framework for the structural understanding
of chromatin remodelling and extend our knowledge of RNA polymerase II stalling in
certain mutational contexts.
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1 Introduction
Deoxyribonucleic acid (DNA) stores the genetic information required for all cellular pro-
cesses. Genomes are inherently large and must be compacted and organized to fit within
their host cell. Bacteria fit their ∼3 mm of genomic DNA within 0.5-1 µm using pro-
teineacous factors within the cytoplasm. Eukaryotes can have genomes that reach 150
billion base pairs (equivalent to 91 meters of non-compacted DNA) and are segregated
in an organelle known as the nucleus. To allow for proper organization, eukaryotes orga-
nize their genomes in a spatio-temporal manner employing a protein-DNA structure called
chromatin. Although compaction of the DNA is necessary for storage, accessibility is also
required to allow for the proper function of cellular processes such as transcription, DNA
replication, and repair.
1.1 Chromatin
Twenty years ago, the Richmond lab solved the crystal structure of a histone octamer
from X. laevis bound to a 146 base pair palindromic DNA from α-satellite DNA (Luger
et al., 1997). This first structure of the nucleosome core particle presented a breakthrough
in the understanding of chromatin at an atomic resolution. A plethora of nucleosome
structures from different organisms have been solved over the last two decades highlighting
a conserved architecture of the nucleosome that extends from Archaea to apes (Luger
et al., 1997; White et al., 2001; Tsunaka et al., 2005; Vasudevan et al., 2010). In contrast,
crystallizing nucleosomes with additional factors bound proved extremely challenging and
resulted only in a handful of structures (Barbera et al., 2006; Makde et al., 2010; Tan and
Davey, 2011; Armache et al., 2011; Kato et al., 2013; McGinty et al., 2014). With the
recent advent of high-resolution single particle cryo-electron microscopy (cryo-EM), it is
now possible to capture structures of nucleosomes bound to individual factors or within
larger assemblies.
1.1.1 Organization of the genome in eukaryotes
Eukaryotes organize their nuclear genome in a densely packed but readily accessible struc-
ture called chromatin. Chromatin is organized in a hierarchical structure. The fundamental
1
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unit is the nucleosome (Kornberg, 1974). The nucleosomes form a ”beads-on-a-string”-like
structure and multiple nucleosomes pack into higher order structures in the presence of
linker histones (e.g. H1) (Simpson, 1978). Both in vitro and in vivo studies converge on
the importance of the tetranucleosome as a packaging unit (Schalch et al., 2005). However,
it remains elusive if the 30 nm chromatin fiber, a hallmark of higher order packaging in
vitro, also exists in vivo (Ou et al., 2017). Nucleosomal arrays are capable of compaction
and can form even more compact structures that are mostly inaccessible to the transcrip-
tion and DNA replication machinery (heterochromatin) (van Steensel, 2011). The highest
and most compacted state of chromatin is found in the metaphase chromosome.
In addition to its packaging function, chromatin also plays a role in preventing DNA
damage and provides regulated access to the genome for important cellular processes such
as DNA replication and DNA-dependent transcription of genes.
1.1.2 Architecture of the nucleosome
The nucleosome is a DNA-protein complex, consisting of∼147 bp of DNA that are wrapped
around a protein core (Figure 1) (Kornberg, 1974; Luger et al., 1997). The protein core
consists of the core histones H2A, H2B, H3, and H4. The core histones share a common
architecture. The histones contain a centrally located histone-fold motif with N- and C-
terminal extensions. The histone fold itself consists of three α helices that are connected
by two flexible loops. The shorter first and third helix pack against the longer central
helix. H2A and H2B form dimers, whereas two H3 and two H4 histones form a tetramer
(Figure 1) (Arents et al., 1991). Two H2A-H2B dimers and one H3-H4 tetramer together
form the histone octamer around which 1.65 turns of DNA are wrapped in a left-handed
superhelical arrangement.
Histone-DNA contacts are mediated by direct hydrogen bonds, ionic interactions, and
nonpolar contacts including hydrogen bonds from water (McGinty and Tan, 2015). The
DNA encloses the histone octamer in two parallel DNA gyres with one side of the nucleo-
some showing a diagonally running DNA that connects the two gyres of nucleosomal DNA.
Overall, this architectural arrangement results in a pseudo-twofold axis which is referred
to as the dyad axis (Flaus et al., 1996). DNA locations are labeled by their superhelical
locations (SHL) with the location at the dyad axis being designated SHL 0. SHLs range
from -7 to +7. The flexible regions of the histones at their N- and C-terminal ends (called
tails) can be covalently post-translationally modified with modifications including phos-
phorylations, acetylation, methylations, and ubiquitinations (Taverna et al., 2007). These
modifications are established or removed by proteins or protein complexes called histone
2
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H2A-H2B
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Figure 1: Architecture of the nucleosome core particle. The nucleosome core particle
consists of the histones H2A, H2B, H3, and H4. 147 bp of DNA are wrapped around the
histone octamer in a left-handed helix.
writers and erasers. Modifications can be read by histone readers (Allis and Jenuwein,
2016).
A hotspot for binding of chromatin factors to the nucleosome is the H2A/H2B acidic
patch. The acidic patch, a signature feature of the nucleosome, is a surface formed by
the H2A/H2B dimer. The surface is formed by ten acidic residues and is a prominent
surface for the binding of chromatin factors. In fact, all available crystal structures of
factors bound to the nucleosome show an interaction between the factor and the acidic
patch (Barbera et al., 2006; Makde et al., 2010; Armache et al., 2011; Kato et al., 2013;
McGinty et al., 2014; Fang et al., 2016).
3
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1.1.3 ATP-dependent chromatin remodellers
The compact packaging of genomic DNA around the nucleosome requires molecular ma-
chines to facilitate and regulate access to the DNA by shifting nucleosomes for important
cellular processes such as DNA replication and transcription. These molecular machines are
called chromatin remodellers. The shifting of nucleosomes happens in an ATP-dependent
manner, driven by an ATPase motor that shows DNA translocase activity. Chromatin
remodellers are essential for the proper maintenance of chromosome function and their
deregulation results in a variety of diseases including cancer and neurodevelopmental dis-
orders (Weiss et al., 2016; Sugathan et al., 2014).
The ATPases involved in chromatin remodelling are part of the superfamily 2 RNA/
DNA helicase family and are classified in four sub-groups (Clapier et al., 2017; Flaus
et al., 2006): the chromodomain helicase-DNA binding (CHD) (Tran et al., 2000), the
switch/sucrose non-fermentable (SWI/SNF) (Neigeborn and Carlson, 1984), the inositol
requiring mutant 80 (INO80) (Ebbert et al., 1999; Shen et al., 2000), and the imitation
switch (ISWI) subfamily (Elfring et al., 1994) (Figure 2). All chromatin remodellers share
a common ATP hydrolysis-driven DNA translocase motor with two RecA-like lobes which
bind the nucleosome at SHL ± 2 (Schwanbeck et al., 2004). Differences in their phenotype
are explained by additional auxiliary domains and factors that play a regulatory role for
the activity of the chromatin remodeller.
Chromatin remodeller subfamilies
The SWI/SNF subfamily contains a centrally located ATPase motor flanked N-terminally
by a HSA (helicase/SANT-associated) and a post-HSA domain and C-terminally by an AT-
hook and a bromodomain (Figure 2a). The HSA domain has been shown to bind actin or
actin-related proteins (Schubert et al., 2013). One of the most prominent members of this
subfamily is the RSC complex (Cairns et al., 1996). The SWI/SNF subfamily facilitates
access to the chromatin by sliding and ejecting nucleosomes from the DNA (Lorch et al.,
1999) and is responsible for activating or repressing gene expression (Mitra et al., 2006).
Whereas the two RecA-like lobes of the SWI/SNF subfamily only contain a short
linker between them, the INO80 subfamily of chromatin remodellers contain a variable
linker length between the two lobes of the ATPase motor (Figure 2b) (Morrison and Shen,
2009). The N-terminus is organized similarly to the SWI/SNF subfamily with a HSA
and a post-HSA domain. Chromatin remodellers belonging to the INO80 subfamily play
critical roles in nucleosomal spacing and accessibility. They are able to edit nucleosomes
by evicting H2A-H2B dimers in exchange for other histone variants (Mizuguchi et al.,
4
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Figure 2: Domain architecture of the chromatin remodeller subfamilies SWI/SNF, INO80,
ISWI, and CHD. Domains present in the subfamilies are indicated and colored. This figure
has been adapted from Clapier et al. (2017).
2004). Through this editing activity, the INO80 subfamily plays a role in DNA repair
by replacing the histone variant H2A.X (van Attikum et al., 2007). Remodellers of the
INO80 subfamily have also been implicated in telomere maintenance (Yu et al., 2007) and
chromosome segregation (Krogan et al., 2004).
The ISWI subfamily ATPase motor is flanked by a regulatory AutoN domain at the
N-terminus and a regulatory NegC domain at the C-terminus (Figure 2c) (Dang and
Bartholomew, 2007). A HSS (HAND-SANT-SLIDE) domain located at the C-terminus
is capable of binding DNA as well as H3 tails (Boyer et al., 2004). ISWI complexes assem-
ble and space nucleosomes on DNA. The subfamily plays a critical role in gene expression
by regulating access to chromatin (Hochheimer et al., 2002).
The CHD subfamily and its member Chd1 in S. cerevisiae will be discussed in a specific
subsection (Figure 2d).
Mechanism of DNA translocation
Chromatin remodelling is defined by the energy landscape of the nucleosome. Biophysical
assays revealed that the DNA is positioned on the nucleosome with a relative stability of
approximately 11-14 kcal mole-1 (Gottesfeld and Luger, 2001). This stability is conferred
by a total of 14 histone-DNA contacts, yielding an energy contribution of ∼1 kcal mole-1
5
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per contact of DNA with the octamer. Estimation of forces required to break one of these
interactions has been estimated to be on the order of ∼1 pN. ATP provides approximately
7 kcal mole-1 of Gibbs free energy, thus chromatin remodellers are not able to provide
the required energy to translocate DNA and remodel a full nucleosome with a single ATP
hydrolysis event. Multiple rounds of ATP hydrolysis are required to successfully remodel
a nucleosome.
Since structures of full-length chromatin remodellers bound to nucleosomes are not yet
available, current models describing the mechanism for DNA translocation are primarily
derived from structural and biochemical characterization of SF2 family helicases (Du¨rr
et al., 2006; Sengoku et al., 2006; Gu and Rice, 2010). The conserved ATPase motor
is formed by the two RecA-like lobes which together form a DNA binding surface and
constitute an ATP binding site. The two lobes bind the DNA in an arrangement where
both bind the same strand (tracking strand) while the lobes are slightly offset. ATP binding
and hydrolysis would then result in a movement of the lobes and cause DNA translocation
(Saha et al., 2002). In this model, the ATPase motor moves unidirectionally relative to the
DNA. If the remodeller is held at a fixed position, the DNA is translocated in one direction
while the ATPase motor ”walks” in the opposite direction.
Biochemical evidence suggests that the motor movement requires one ATP hydrolysis
event per 1-2 bp of translocated DNA (Zhang et al., 2006; Harada et al., 2016). On a
nucleosome, the ATPase motor seems to be stably bound at SHL 2 (Kagalwala et al., 2004;
Schwanbeck et al., 2004). DNA translocation would then result in creation of torsional
stress of DNA on the entry and exit side of nucleosomal DNA. Based on these assumptions,
a model called the wave-ratchet-wave model has been proposed which is signified by one-
dimensional diffusion of DNA along the nucleosome to shift nucleosomes (Clapier et al.,
2017). The model proposes that the introduction of torsional stress by the ATPase motor
breaks histone-DNA contacts. The DNA segment closer to the dyad then propagates in a
wave-like fashion toward the DNA exit side, while the torsional restraints on the other side
of the ATPase motor results in the ”pulling in” of entry side DNA (Saha et al., 2005). This
ultimately resolves the torsional stress introduced by the chromatin remodeller. It remains,
however, unclear what size such a wave has (Saha et al., 2006). Many repeated enzymatic
cycles of the ATPase motor eventually result in shifting or eviction of the nucleosome.
Chd1
Chd1 is a member of the CHD subfamily of chromatin remodellers. This subfamily is
named after its unique tandem chromodomains that are arranged at the amino terminus
6
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of the remodeller. This double chromodomain is followed by the conserved ATPase mo-
tor consisting of two RecA-like lobes. It is followed by a DNA-binding region with two
domains (SANT and SLIDE). Recently, an additional domain was discovered at the car-
boxy terminus of S. cerevisiae Chd1 called CHCT (Mohanty et al., 2016). Whereas the
CHD subfamily has eight members in H. sapiens that have different additional auxiliary
domains, the baker’s yeast S. cerevisiae only has one member in the CHD subfamily, Chd1.
CHD chromatin remodellers have been implicated in a range of cellular processes including
maintenance of pluripotency in stem cells (Gaspar-Maia et al., 2009) and Chd1-dependent
emergence of hematopoietic progenitor cells from endothelial cells (Koh et al., 2015). Chd1
plays also a role during transcription (Zentner et al., 2013). System-wide genomic studies
have shown that Chd1 is located both at the promotor and within the coding regions of
genes, probably accompanying RNA polymerase II to maintain and optimize nucleosomal
localization during transcription (Zentner et al., 2013; Smolle et al., 2012).
Chd1 in S. cerevisiae is a single-subunit chromatin remodeller with the classical CHD
subfamily domain organization. The CHCT domain has a positively charged surface and
is able to interact with DNA and nucleosomes (Mohanty et al., 2016). Whereas the double
chromodomain of human CHD1 binds H3 tails trimethylated at residue K4, yeast Chd1
cannot bind the modification due to a mutation in the aromatic cage that is required
for binding the modified tail (tryptophan in human substituted to glutamate in yeast)
(Sims et al., 2005). Chd1 has been shown to be recruited to open reading frames by the
transcription elongation factor complex Paf1C (polymerase associated factor 1 complex)
through its subunit Rtf1 (Simic et al., 2003).
Chd1 shifts nucleosomes away from DNA ends and biochemical data suggests that this
characteristic is mediated by the DNA-binding region (McKnight et al., 2011; Patel et al.,
2013). Chd1 shows ATPase activity on linear DNA, however, it is greatly stimulated in the
presence of nucleosomes, suggesting that Chd1 can distinguish linear DNA from nucleoso-
mal DNA. Recently, the Bowman lab has shown via site-specific cross-linking experiments
that Chd1 binds both DNA gyres and can ”communicate over an ∼90 bp loop of nucle-
osomal DNA” (Nodelman et al., 2017). Structural data for S. cerevisiae Chd1 exists. A
crystal structure of the double chromodomain with the ATPase motor revealed an auto-
inhibited state where a region in the double chromodomain (the acidic wedge) sequesters
a basic region in ATPase lobe 2 (Hauk et al., 2010) (Figure 3a). This forces ATPase lobe
2 to stay in a conformation that is not catalytically competent. A model proposes that
the presence of nucleosomal DNA could alleviate this process of inhibition. Additionally,
a crystal structure of the DNA-binding region of Chd1 with the SANT and SLIDE do-
mains was solved in 2011 (Sharma et al., 2011) (Figure 3b). The structure revealed that
7
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the SANT and SLIDE domains preferentially bind linear DNA which is consistent with a
preference of the DNA-binding region for extranucleosomal DNA.
a b
ATPase
lobe 2
ATPase
lobe 1
Double
chromodomain
HL1/β-linker
SANT
SLIDE
DNA binding region
DNA
Figure 3: Crystal structures of the domains of Chd1. a. Crystal structure of the ATPase
motor with the double chromodomain of Chd1 (PDB code 3MWY, Hauk et al. (2010)).
ATPase lobe1, lobe2 and the double chromodomain are indicated in orange, green, and
purple. The acidic wedge in the double chromodomain interacts with a basic region of
ATPase lobe 2. b. Crystal structure of the DNA-binding region of Chd1 in complex with
double-stranded DNA (PDB code 3TED, Sharma et al. (2011)). The SANT, SLIDE, and
the HL1/β-linker are indicated with blue, magenta, and green ovals. The DNA-binding
region is colored in pink.
1.2 Transcription
Transcription is the first step of gene expression, whereby RNA chain assembly is catalysed
by DNA-dependent RNA polymerases. RNA polymerases are conserved in prokaryotes,
archaea, and eukaryotes (Werner and Grohmann, 2011). Whereas bacteria and archaea
only possess one RNA polymerase (Pol), eukaryotes have RNA polymerase I, II and III
(Roeder and Rutter, 1969). Plants even possess two additional RNA polymerases (IV and
V). RNA polymerase I and III primarily transcribe rRNA (Pol I and Pol III), tRNAs
(Pol III) and other small RNAs (Pol III). Pol II synthesizes nascent mRNA, snRNA and
microRNAs. RNA polymerase II is a ∼500 kDa protein complex, consisting of 12 subunits.
Pol II activity is tightly regulated by a great number of transcription factors to tune
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transcription of genes depending on the environmental context. I will discuss factors and
activities of the Pol II transcription cycle (Figure 4).
Pol II
TSS
Nucleosome
CTD with
phosphorylations
RNA with 5’ cap
Initiation Elongation Termination
poly(A)
+ Initiation factors
TFIIA
TFIIB
TFIID
TFIIE
TFIIF
TFIIH
SAGA
Mediator
+ Elongation factors
Spt4/5
Spt6
Paf1C
FACT
Chd1
Bur1/2
Ctk1/2/3
+ Termination factors
Rat1
Rai1
Glc7
CPF
Figure 4: Schematic of the transcription cycle. Initiation, elongation and termination are
shown schematically. Yeast factors that have been shown to be involved in the transcription
cycle are shown. Factors that interact with chromatin are shown in light blue. Chd1 is
highlighted in red.
1.2.1 Transcription initiation
Transcription of protein-coding genes starts with the first step of the transcription cycle,
called transcription initiation (Hantsche and Cramer, 2017). During transcription initiation
in the Pol II system, general transcription factors and RNA polymerase II assemble together
on a promoter (Sainsbury et al., 2015). This process has been studied extensively using
functional and structural approaches (Sainsbury et al., 2013; He et al., 2016; Plaschka
et al., 2016). RNA polymerase II assembles with TFIIA, TFIIB, TFIID, TFIIE, TFIIF,
and TFIIH on promotor DNA. Most protein-coding genes, additionally, are controlled by
the co-activator Mediator (Plaschka et al., 2015). Pol II and the initiation factors melt
the DNA in a nucleotide dependent manner. The melted DNA allows for Pol II to initiate
nascent RNA synthesis from within a ”transcription bubble”.
1.2.2 Transcription elongation
After transcription initiation and promoter escape, RNA polymerase II enters the elon-
gation phase of the transcription cycle (Jonkers and Lis, 2015). During this phase of
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transcription, RNA polymerase II has escaped the promoter, maintains the transcription
bubble and catalyses the addition of nucleotides to the growing 3’ end of RNA by a Brown-
ian ratchet mechanism (Martinez-Rucobo and Cramer, 2013). The molecular mechanism of
elongation and its regulation have been studied in a wide range of crystallographic studies
in the yeast system as well as the bacterial system, revealing a conserved catalytic center
and mechanism of transcription among bacteria and eukaroytes (Figure 5) (Cramer et al.,
2001; Vassylyev et al., 2007a).
Elongation undergoes allosteric regulation by a range of elongation factors such as
Spt4/5 in yeast (DSIF in human), Spt6, Elf1, TFIIS, and Paf1C (Clark-Adams and Win-
ston, 1987). Recently, the study of transcription elongation has expanded to cryo-EM to
better understand the regulation of this process in the presence of additional regulatory
factors (Xu et al., 2017; Bernecky et al., 2017; Ehara et al., 2017).
Bridge helix Trigger loop
Metal A
NTP   
binding
site
Upstream DNA
Downstream 
DNA     RNA
Template 
DNA
Non-template 
DNA
a b
NTP 
substrate
D485
D483
D481
3’ 5’
RNA
5’
3’
5’
Trigger loop
Bridge helix
Metal A
Figure 5: Architecture of the Pol II EC and Pol II active site. a. Overview of the S.
cerevisiae RNA polymerase II elongation complex (PDB code 3HOV) (Sydow et al., 2009).
Template strand, non-template strand, RNA, bridge helix, trigger loop, and metal A are
colored in dark blue, cyan, red, green, yellow and pink, respectively. Color scheme is used
throughout the figure. Missing amino acids for the trigger loop are indicated as yellow
dotted line. NTP binding site is indicated as a red, dotted oval. b. Active site of the
Pol II EC. Conserved aspartate residues that coordinate metal A are shown as sticks in
white. A non-hydrolyzable NTP (AMPCPP) was used to obtain a structure with the NTP
substrate bound (PDB code 4A3F) (Cheung et al., 2011).
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Nucleotide addition cycle
During elongation, Pol II catalyses the addition of nucleotides to a growing RNA chain in
a DNA-directed manner (Cheung and Cramer, 2012). Nucleotide addition can be thought
of as a catalytic cycle (nucleotide addition cycle) (Hantsche and Cramer, 2016). In the
cycle, a nucleotide enters the active site of Pol II at the nucleotide addition site. Pol II
selects the correct NTP using hydrogen bonding between the template DNA and the NTP,
catalyzes the addition of the selected NTP to the 3’ end of the RNA, translocates along
the template DNA to free the catalytic site, and allows for the next NTP to bind at the
nucleotide addition site (Martinez-Rucobo and Cramer, 2013). The cycle is then repeated.
The NTP substrate binds at the nucleotide addition site between the 3’ end of the RNA
and the bridge helix. NTP selection is then performed in a two-step mechanism (Westover
et al., 2004; Kettenberger et al., 2004; Sydow and Cramer, 2009; Cheung et al., 2011).
Presence of the NTP in the nucleotide addition site causes a structural rearrangement of
the mobile trigger loop. The rearrangement closes the active site and the NTP moves to
a position (insertion site) where all contacts required for catalysis are satisfied. Catalysis
is then realized by a two-metal ion mechanism (Vassylyev et al., 2007b). One of the two
magnesium ions involved in catalysis is coordinated by three conserved aspartate residues
and the RNA 3’ end, while metal B appears to be more flexible. Upon catalysis, metal
B is bound by the NTP substrate. Nucleotide addition then follows a SN2 nucleophilic
substitution (Yee et al., 1979; Armstrong et al., 1979). The 3’-OH of the RNA acts as
the nucleophile that attacks the α-phosphate of the NTP. The nucleotide forms a covalent
bond with the RNA and is now part of the growing RNA chain. The catalysis releases one
pyrophosphate. It has been proposed that the pyrophosphate release causes unfolding of
the trigger loop to allow for a new round of the nucleotide addition cycle after translocation
(Brueckner and Cramer, 2008; Martinez-Rucobo and Cramer, 2013).
Mechanism of translocation
After one nucleotide addition cycle, the insertion site of the active site of RNA polymerase
II is occupied (pre-translocated state) and translocation of the DNA and RNA is required
to allow for the next round of substrate addition. Translocation is performed in one base
steps and is based on a Brownian ratchet mechanism. The mechanism of translocation was
elucidated through a number of structural studies (Brueckner and Cramer, 2008; Bushnell
et al., 2002). The initial Pol II core structure bound to nucleic acid captured the pre-
translocated state (Gnatt et al., 2001) and subsequent structural studies have captured
the enzyme in the post-translocated state. Additionally, a structure of Pol II bound by the
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mushroom toxin α-amanitin captured an intermediate state between the pre- and post-
translocated state (Brueckner and Cramer, 2008). This structure led to the proposal of a
two-step translocation mechanism where the release of the pyrophosphate causes unfolding
of the trigger loop. This unfolding leads to a cooperative movement of the newly formed
hybrid base pair out of the active site and bending of the bridge helix which was previously
locked (ratchet-like), ultimately resulting in the translocation to the post-translocated
state. Overall, translocation frees the nucleotide addition site and the next NTP can bind.
1.2.3 Transcription termination
Successful transcription elongation is followed by transcription termination to conclude
the transcription cycle of RNA polymerase II (Porrua and Libri, 2015; Proudfoot, 2016).
The 3’ end of genes is marked by the poly(A) site. In contrast to Pol I and Pol III, RNA
polymerase II does not terminate in a sequence-specific manner but rather termination
sites are located in an approximately several thousand base pairs window past the poly(A)
signal (Nojima et al., 2013). When Pol II transcribes over the poly(A) site, the RNA is
cleaved and a poly(A) tail is added to the 3’ end of the RNA. It remains unclear how
transcription termination works mechanistically and structures are largely lacking. It has
been postulated that termination may require Pol II clamp opening and conformational
changes in the elongation factor Spt4/5 during termination (Richard and Manley, 2009;
Schreieck et al., 2014). The pre-termination complex is postulated to be inherently labile,
making its study difficult.
Based on biochemical and functional genomics data, two models for transcription termi-
nation are proposed. The torpedo model proposes that a 5’-3’ exonuclease (Rat1 in yeast,
XRN2 in human) is recruited by a CTD-interacting protein (Rtt103 in yeast) and degrades
the nascent RNA after cleavage by the CPF-CF complex (Kim et al., 2004; West et al.,
2004). The exonuclease then dissociates Pol II from the DNA-RNA hybrid by catching up
with polymerase and driving Pol II off of its substrate in a torpedo-like fashion (Connelly
and Manley, 1988). The allosteric model proposes that a change in the elongation factors
that associate with Pol II or conformational changes in the polymerase itself destabilize the
previously stable elongation complex, resulting in dissociation of RNA polymerase II from
the DNA-RNA hybrid (Richard and Manley, 2009). These two models are not mutually
exclusive and there is evidence that both models could play a role in a unified mechanism
of transcription termination (Luo et al., 2006).
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1.3 Aims and scope of this work
Chromatin remodelling is required for DNA replication, DNA repair and transcription. The
single-subunit chromatin remodeller Chd1 centers nucleosomes on DNA and can induce a
regular nucleosome pattern. It plays a key role in cell pluripotency (Gaspar-Maia et al.,
2009) and is essential for RNA polymerase II passage through chromatin (Skene et al.,
2014).
I determined the structure of full-length S. cerevisiae Chd1 bound to a nucleosome core
particle at a nominal resolution of 4.8 A˚. Chd1 binds the NCP on one side of the nucleosome
and peels two full helical turns of nucleosomal DNA away from the histone octamer. The
ATPase motor binds the NCP at SHL +2. Based on previously published structures, I
was able to determine a mechanism of regulation for Chd1 where the regulatory double
chromodomain contacts DNA at SHL +1 and releases ATPase lobe 2 to allow for lobe
2 closure. Comparison of our structure with the structure of a NCP-Snf2 complex (Liu
et al., 2017) revealed a model for the mechanism of ATPase translocation where binding
of ATP results in translocation of ATPase lobe 2 from a pre- to a post-translocated state
that causes DNA translocation. ATP hydrolysis results in resetting of the ATPase motor
and the enzymatic cycle can begin again. The observed conformation allowed assignment
of the translocase activity of Chd1. Chd1 is a 3’-5’ translocase, which translocates DNA
towards the octamer dyad.
It has been shown that DNA alkylations present in minor groove alkylation adducts
can stall transcription elongation. In order to understand how these alkylation adducts
alter transcription, I solved the 3.2 A˚ resolution crystal structure of a S. cerevisiae RNA
polymerase II elongation complex with an alkylated base present opposite the nucleotide
addition site. Based on biochemical work and structural interpretation, it was possible to
characterize a novel mechanism of Pol II stalling in the presence of this class of modified
bases. Pol II likely stalls due to a clash between the DNA adduct and the mobile trigger loop
which is required for proper RNA chain synthesis and translocation during the nucleotide
addition cycle.
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2 Materials & Methods
This chapter lists strains, buffers, oligonucleotides and other materials used in the pre-
sented work. It additionally provides protocols for all presented work that is part of this
dissertation.
Parts of this section have been published or are in the process of being published:
Lucas Farnung, Seychelle M. Vos, Christoph Wigge, Patrick Cramer. (2017) Nucleosome-
Chd1 structure and implications for chromatin remodelling. Nature. doi: 10.1038/na-
ture24046 (in press)
Stefano Malvezzi*, Lucas Farnung*, Claudia Aloisi, Todor Angelov, Patrick Cramer,
Shana J. Sturla. (2017) Mechanism of RNA polymerase II stalling by DNA alkylation
PNAS. (accepted in principle)
*Both authors contributed equally.
2.1 Materials
2.1.1 Strains
Bacterial strains
Table 1: E. coli strains used in this study
Strain Genotype Source
BL21-Codon Plus(DE3)-RIL B F- ompT hsdS(r b - mb-) dcm+ Tetr
gal λ(DE3) endA Hte [argU ileY LeuW
Camr]
Stratagene
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17
supE44 relA1 lac [F’ proAB lacIq
ZΔM15 Tn10 (Tetr)]
Stratagene
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DH10EMBacY F-mcrAΔ(mrr-hsdRMS-mcrBC)
φ80lacZΔM15 ΔlacX74 recA1 endA1
araD139 Δ(ara, leu)7697 galU galK
λ-rpsL nupG/EMBacY/pMON7124
Geneva Biotech
Insect cell strains
Table 2: Insect cell strains used in this study
Strain Species Source
Sf9 Spodoptera frugiperda Life Technologies
Sf21 (IPLB-Sf-21-AE) Spodoptera frugiperda Expression Systems, LLC
Hi5 (T. ni) Trichoplusia ni Expression Systems, LLC
Yeast strains
Table 3: Saccharomyces cerevisiae strain used in this study
Strain Genotype Source
BJ5464 BJ5464 Rpb3 His-Bio tag introduced at the N-terminus
of Rpb3
Kireeva et al., 2000
2.1.2 Plasmids
Table 4: Plasmids used in this study
Vector Insert Type Source
438-A Untagged 438 series UC Berkeley
438-B N-terminal His 6× tag and a TEV protease cleav-
age site
438 series UC Berkeley
438-C N-terminal His 6× tag, MBP tag, N10 linker and
a TEV protease cleavage site
438 series UC Berkeley
Spt16 438-C vector with S. cerevisiae Spt16 with N-
terminal His 6× tag, MBP tag, N10 linker and
a TEV protease cleavage site
438 series This study
Pob3 438-A vector with S. cerevisiae Pob3 438 series This study
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FACT S. cerevisiae Spt16 with N-terminal His 6× tag,
MBP tag, N10 linker and a TEV protease cleavage
site, and S. cerevisiae Pob3
438 series This study
Chd1 S. cerevisiae Chd1 with N-terminal His 6× tag,
MBP tag, N10 linker and a TEV protease cleavage
site
438 series This study
H2A pET3A vector with X. laevis H2A pET series Halic Lab
H2B pET3A vector with X. laevis H2B pET series Halic Lab
H3 pET3A vector with X. laevis H3 pET series Halic Lab
H4 pET3A vector with X. laevis H4 pET series Halic Lab
2.1.3 Oligonucleotides
Table 5: Oligonucleotides used for generation of nucleosomal DNA, crystallization, and
transcription assays
Type Sequence (5’-3’) Application
Template DNA ACC TCA ACT ACT
TG(3-deaza-3-NAPHT-dA)
CCC (5-bromo-U)CC TCA
TT
Crystallization
Non-template DNA CAA GTA GTT GAG GT Crystallization
RNA UUC GAG GAG GG Crystallization
Forward Primer CGC TGT TTT CGA ATT
TAC CCT TTA TGC GCC
GGT ATT GAA CCA CGC
TTA TGC CCA GCA TCG
TTA ATC GAT GTA TAT
ATC TGA CAC GTG CCT
Nucleosome reconstitution
Reverse Primer ATC AGA ATC CCG GTG
CCG AG
Nucleosome reconstitution
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2.1.4 Buffers and solutions
Table 6: Buffers used for purification of S. cerevisiae Chd1
Name Description
Lysis buffer 300 mM NaCl, 20 mM Na·HEPES pH 7.4, 10 % (v/v) glycerol, 1
mM DTT, 30 mM imidazole pH 8.0, 0.284 µg/ml leupeptin, 1.37
µg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml benzamidine
High Salt Buffer 1000 mM NaCl, 20 mM Na·HEPES pH 7.4, 10 % (v/v) glycerol, 1
mM DTT, 30 mM imidazole pH 8.0, 0.284 µg/ml leupeptin, 1.37
µg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml benzamidine
Nickel elution buffer 300 mM NaCl, 20 mM Na·HEPES pH 7.4, 10 % (v/v) glycerol, 1
mM DTT, 500 mM imidazole pH 8.0, 0.284 µg/ml leupeptin, 1.37
µg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml benzamidine
Dialysis buffer 300 mM NaCl, 20 mM Na·HEPES pH 7.4, 10 % (v/v) glycerol, 1
mM DTT, 30 mM imidazole pH 8.0
Gel Filtration buffer 300 mM NaCl, 20 mM Na·HEPES pH 7.4, 10 % (v/v) glycerol, 1
mM DTT
Table 7: Buffers used for purification of S. cerevisiae FACT
Name Description
Lysis buffer 300 mM NaCl, 20 mM Na·HEPES pH 7.4, 10 % (v/v) glycerol, 1
mM DTT, 30 mM imidazole pH 8.0, 0.284 µg/ml leupeptin, 1.37
µg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml benzamidine
High Salt Buffer 1000 mM NaCl, 20 mM Na·HEPES pH 7.4, 10 % (v/v) glycerol, 1
mM DTT, 30 mM imidazole pH 8.0, 0.284 µg/ml leupeptin, 1.37
µg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml benzamidine
Nickel elution buffer 300 mM NaCl, 20 mM Na·HEPES pH 7.4, 10 % (v/v) glycerol, 1
mM DTT, 500 mM imidazole pH 8.0, 0.284 µg/ml leupeptin, 1.37
µg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml benzamidine
Dialysis buffer 150 mM NaCl, 20 mM Na·HEPES pH 7.4, 10 % (v/v) glycerol, 1
mM DTT, 30 mM imidazole pH 8.0
Gel Filtration buffer 300 mM NaCl, 20 mM Na·HEPES pH 7.4, 10 % (v/v) glycerol, 1
mM DTT
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Table 8: Buffers used for purification of S. cerevisiae Paf1C
Name Description
Lysis buffer 50 mM Tris-HAc (pH 8.7 at 4 °C), 600 mM KAc, 2 mM
MgCl2, 10 mM imidazole, 2 mM DTT, pH 8.0, 0.284
µg/ml leupeptin, 1.37 µg/ml pepstatin A, 0.17 mg/ml
PMSF, 0.33 mg/ml benzamidine
Denatured protein wash buffer 2mg/mL denatured protein, 50 mM Tris-HAc (pH 8.7
at 4 °C), 600 mM KAc, 2 mM MgCl2, 10 mM imida-
zole, 2 mM DTT, pH 8.0, 0.284 µg/ml leupeptin, 1.37
µg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml
benzamidine
Ni elution buffer 50 mM Tris-HAc (pH 8.7 at 4 °C), 150 mM KAc, 2 mM
MgCl2, 150 mM imidazole, 2 mM DTT, pH 8.0, 0.284
µg/ml leupeptin, 1.37 µg/ml pepstatin A, 0.17 mg/ml
PMSF, 0.33 mg/ml benzamidine
HiTrap SP Buffer 0 50 mM Tris-HAc (pH 8.7 at 4 °C), 2 mM MgCl2, 2 mM
DTT
HiTrap SP Buffer 2000 50 mM Tris-HAc (pH 8.7 at 4 °C), 2000 mM KAc, 2
mM MgCl2, 2 mM DTT
Gel filtration buffer 10 mM Tris-HCl (pH 8.5 at 4 °C), 200 mM NaCl, 2
mM MgCl2, 10 % (v/v) glycerol, 2 mM DTT
Table 9: Buffers used for purification of X. laevis histones
Name Description
Wash buffer 100 mM NaCl, 50 mM Tris-HCl pH 7.5, 2 mM DTT, 1 mM Na-EDTA
pH 8.0, 0.284 µg/ml leupeptin, 1.37 µg/ml pepstatin A, 0.17 mg/ml
PMSF, 0.33 mg/ml benzamidine
TW buffer 100 mM NaCl, 50 mM Tris-HCl pH 7.5, 2 mM DTT, 1 mM Na-EDTA
pH 8.0, 1 % (v/v) Triton X-100 0.284 µg/ml leupeptin, 1.37 µg/ml
pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml benzamidine
Unfolding buffer 7 M guanidine hydrochloride, 20 mM Tris-HCl pH 7.5, 10 mM DTT
SAU-200 7 M deionized urea (freshly deionized), 20 mM sodium acetate pH
5.2, 200 mM NaCl, 1 mM Na-EDTA pH 8.0, 2 mM DTT
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Name Description
SAU-1000 7 M deionized urea (freshly deionized), 20 mM sodium acetate pH
5.2, 1000 mM NaCl, 1 mM Na-EDTA pH 8.0, 2 mM DTT
Dialysis Buffer 15 mM Tris-HCl pH 7.5, 2 mM DTT
Table 10: Buffers used for purification of S. cerevisiae Rpb4/7
Name Description
Freezing buffer 50 mM Tris pH 7.5 at 4 ◦C, 150 mM NaCl, 10 % (v/v) glyc-
erol, 0.852 µg/ml leupeptin, 4.11 µg/ml pepstatin A, 0.51 mg/ml
PMSF, 0.99 mg/ml benzamidine
Buffer0 50 mM Tris pH 7.5 at 4 ◦C, 150 mM NaCl, 10 mM β-
mercaptoethanol, 0.284 µg/ml leupeptin, 1.37 µg/ml pepstatin
A, 0.17 mg/ml PMSF, 0.33 mg/ml benzamidine
Buffer10 50 mM Tris pH 7.5 at 4 ◦C, 150 mM NaCl, 10 mM β-
mercaptoethanol, 10 mM imidazole, 0.284 µg/ml leupeptin, 1.37
µg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml benzamidine
Buffer20 50 mM Tris pH 7.5 at 4 ◦C, 150 mM NaCl, 10 mM β-
mercaptoethanol, 20 mM imidazole, 0.284 µg/ml leupeptin, 1.37
µg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml benzamidine
Buffer50 50 mM Tris pH 7.5 at 4 ◦C, 150 mM NaCl, 10 mM β-
mercaptoethanol, 50 mM imidazole, 0.284 µg/ml leupeptin, 1.37
µg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml benzamidine
Buffer200 50 mM Tris pH 7.5 at 4 ◦C, 150 mM NaCl, 10 mM β-
mercaptoethanol, 200 mM imidazole, 0.284 µg/ml leupeptin, 1.37
µg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml benzamidine
Salt buffer 50 mM Tris pH 7.5 at 4 ◦C, 2 M NaCl, 10 mM β-mercaptoethanol,
0.284 µg/ml leupeptin, 1.37 µg/ml pepstatin A, 0.17 mg/ml
PMSF, 0.33 mg/ml benzamidine
SourceQ0 20 mM Tris pH 7.5 at 4 ◦C, 1 mM EDTA, 10 mM DTT
SourceQ2000 20 mM Tris pH 7.5 at 4 ◦C, 2 M NaCl 1 mM EDTA, 10 mM DTT
Gel Filtration Buffer 5 mM HEPES pH 7.25 at 20 ◦C, 40 mM (NH4)SO4, 2 M NaCl,
10 µM ZnCl2, 10 mM DTT
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Table 11: Buffers used for purification of S. cerevisiae RNA polymerase II (BJ5464 strain)
Name Description
Freezing buffer 150 mM Tris pH 7.9 at 4 °C, 3 mM EDTA, 30 µM ZnCl2 , 30 %
(v/v) glycerol, 3 % (v/v) DMSO, 30 mM DTT, 0.852 µg/ml leu-
peptin, 4.11 µg/ml pepstatin A, 0.51 mg/ml PMSF, 0.99 mg/ml
benzamidine
HSB150 50 mM Tris pH 7.9 at 4 °C, 150 mM KCl, 1 mM EDTA, 30
µM ZnCl2, 10 % (v/v) glycerol, 2.5 mM DTT, 0.284 µg/ml leu-
peptin, 1.37 µg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33 mg/ml
benzamidine
HSB1000/7 50 mM Tris pH 7.9 at 4 °C, 1000 mM KCl, 7 mM imidazole, 1 mM
EDTA, 30 µM ZnCl2, 10 % (v/v) glycerol, 2.5 mM DTT, 0.284
µg/ml leupeptin, 1.37 µg/ml pepstatin A, 0.17 mg/ml PMSF,
0.33 mg/ml benzamidine
Ni buffers 20 mM Tris pH 7.9 at 4 °C, 150 mM KCl, 7/50/100 mM imidazole
MonoQ 150 20 mM Tris-acetate pH 7.9 at 4 °C, 150 mM KAc, 10 % (v/v)
glycerol, 0.5 mM EDTA, 10 µM ZnCl2, 10 mM DTT
MonoQ 2000 20 mM Tris-acetate pH 7.9 at 4 °C, 2000 mM KAc, 10 % (v/v)
glycerol, 0.5 mM EDTA, 10 µM ZnCl2, 10 mM DTT
Gel Filtration Buffer 10 mM HEPES pH 7.0 at 20 °C, 200 mM KCl, 5 % (v/v) glycerol,
2 mM DTT
2.1.5 Media and additional components
Table 12: Growth media for E. coli
Media Components
LB 1 % (w/v) tryptone, 0.5 % (w/v) yeast extract, 0.5 % (w/v) NaCl
2× YT 1.6 % (w/v) Bacto tryptone, 1 % (w/v) Bacto yeast extract, 0.5 % (w/v) NaCl
Table 13: Media for cell expression
Media Company
Sf-900 SFM III Life Technologies
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ESF921 Expression Systems, LLC.
Table 14: Antibiotics and additives used for E. coli
Antibiotic/Additive Stock concentration Final concentration
Ampicillin 100 mg/mL 100 µg/mL
Chloramphenicol 34 mg/mL 34 µg/mL
Kanamycin 50 mg/mL 50 µg/mL
Gentamycin 10 mg/mL 50 µg/mL
X-Gal 150 mg/mL 150 µg/mL
IPTG 1 M 1 mM
X-TremeGENE9 (Sigma-Aldrich)
2.2 Methods
2.2.1 Cloning and related techniques
Polymerase Chain Reaction (PCR)
Polymerase chain reactions were carried out with Phusion High Fidelity DNA Polymerase
in 50 µ L reactions, unless stated otherwise. Primer annealing temperatures were calculated
with SnapGene and designed to have an annealing temperature of 60 °C. The following
reaction scheme was used:
Table 15: Reaction for PCR
Component Volume
5× HF Buffer 10 µL
10× 10 mM dNTP 10 µL
10 µM Primer 1 2.5 µL
10 µM Primer 2 2.5 µL
Template DNA 150 ng
DMSO 3 µL
H2O Up to 50 µL
The 2-step PCR program was run with the following parameters:
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Table 16: Two-step PCR program
T in °C Time Loop
98 1 min
98 10 sec
72 8 min Back to step 2, Loop 33×
72 10 min
4 Pause
If applicable, PCR templates were digested with DpnI. PCR products were mixed with
loading dye and separated by agarose electrophoresis. Relevant products were subsequently
purified using the QIAquick Gel Extraction Kit (Qiagen).
Electrophoretic separation of DNA using agarose gels
Agarose gel electrophoresis was performed to separate DNA products. The gel contained
1 % (v/v) agarose, 1 × TAE buffer and 0.5 µg/mL SybrSafe (Invitrogen). Based on the
sample volume, appropriate combs were chosen for gel electrophoresis. DNA samples were
loaded on the gel with a size marker (1 kb DNA ladder, NEB). The gel was subsequently
run in 1 × TAE buffer at 120 V until satisfactory separation of the DNA was achieved.
Gel visualization was achieved using a gel imaging system (Intas Go¨ttingen, Germany).
Restriction digests
Restriction digests with the appropriate restriction enzymes are performed in 20 µL or
50 µL reactions. Restriction enzymes from the manufacturer NEB (New England Biolabs)
were used in this study. Restriction enzyme buffers were chosen based on recommendations
by NEB. Restriction digests were performed for 3 hours at the appropriate temperature.
Digested vectors were applied to an agarose gel and purified using the QIAquick Gel Ex-
traction Kit (Qiagen).
Ligation independent cloning
Ligation independent cloning (LIC) is a cloning technique that does not require endonu-
clease activity for overhang generation or ligase activity. LIC is an attractive technique
to clone genes because inherent restriction sites present in the gene sequence do not affect
cloning.
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To perform LIC, 438-series vectors were digested with the restriction enzyme SspI in
the following reaction:
Table 17: Reaction for LIC restriction digest of a plasmid
Component Volume
Vector (2 µ g) variable
CutSmart Buffer 5 µL
SspI-HF 1 µL
100 mM DTT 1 µL
H2O Up to 50 µL
Inserts and linearized plasmids are treated with T4 DNA polymerase in a LIC reaction using
the exonuclease activity of T4 DNA polymerase to generate sequence specific overhangs.
Table 18: LIC reaction for plasmid
Component Volume
gel purified linearized vector (50-150 ng) 10 µL
25 mM dGTP stock 2 µL
T4 DNA pol 10× buffer 2 µL
100 mM DTT 1 µL
T4 DNA polymerase 0.4 µL
H2O 0.4 µL
The reaction is incubated at 22 °C for 30 minutes and 20 minutes at 75 °C. Inserts (e.g.
generated by PCR) are LIC-treated in the following reaction:
Table 19: Reaction for LIC reaction of insert
Component Volume
gel purified linearized insert (50-150 ng) 10 µL
25 mM dCTP stock 2 µL
T4 DNA pol 10× buffer 2 µL
100 mM DTT 1 µL
T4 DNA polymerase 0.4 µL
H2O 0.4 µL
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The reaction is incubated at 22 °C for 30 minutes and 20 minutes at 75 °C.
After LIC treatment, 2 µL of LIC-treated plasmid and 2 µL of LIC-treated insert are
combined and incubated for 10 min at RT to anneal the generated overhangs. 2.5 µL of
the annealed mixture are then transformed into chemically competent cells.
To combine multiple genes into one vector, one plasmid containing one gene is linearized
with SwaI generating the ”vector” DNA, and the gene to be added, ”insert” is generated
with PmeI digest. The restriction digested fragments are then gel-purified, and undergo
an additional round of LIC cloning.
Circular extension polymerase cloning
Circular extension polymerase cloning (CPEC) is a cloning technique to generate multi-
part DNA assemblies (Quan and Tian, 2011). It is based on generating overhangs that
prime each other during a PCR reaction.
To design a CPEC reaction, overlaps need to be generated with an annealing temper-
ature of 70 °C using the NEB Tm Calculator.
The PCR reaction is then setup in the following way:
Table 20: CPEC reaction
Component Volume
Q5 5× buffer 10 µ L
dNTPs 4 µ L
gel purified, linear plasmid 150 ng vector
gel purified PCR product/insert 200 ng vector
Q5 DNA polymerase 0.5 µ L
H2O Fill up to 50 µL
The following PCR program is used:
Table 21: PCR program for CPEC reaction
Temperature in °C Time Loop
98 30 sec
98 10 sec
70-55 0.1 s for each temperature change
for 3 min
55 30 sec Back to step 1, Loop 26×
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72 5 min
4 Pause
After the PCR 40 µL of the CPEC reaction are added to 100 µL of chemically competent
XL1 blue cells. The competent cells are transformed as described in the next section.
Transformation of chemically competent cells
DNA of interest was added to 100 µL of chemically competent cells. The cells were in-
cubated for 25 minutes on ice. Subsequently, the cells were heat-shocked at 42 °C for 45
seconds and incubated on ice for 2 minutes. 900 µL of LB medium without any selection
marker were added to the cells. The cell suspension was incubated for 1-4 hours at 37 °C
and 300 rpm.
Transformation of electrocompetent cells
500 ng of purified plasmid were added to 100 µL of electrocompetent cells. The cells were
incubated for 10 minutes on ice. After incubation, the cells were transferred to a Gene
Pulser/MicroPulser Cuvettes (0.1 cm gap) (Biorad) and pulsed using a Biorad MicroPulser
with the following settings: 2.5 µF, 1.8 kV. After pulsing, 1 mL of LB medium was added
to the pulsed cell resuspension and transferred to a 15 mL falcon. The cells were outgrown
for six hours before being plated on the appropriate selection media.
Isolation of plasmid DNA
Transformed cells were plated on agarose plates with appropriate, selective antibiotics.
Single colonies were picked from the plates and 5 mL or 50 mL LB medium with the
appropriate antibiotics were inoculated. Cultures were grown overnight at 37 °C and 160
rpm. Plasmid DNA was isolated using the QIAprep Spin Miniprep Kit.
Verification of plasmid DNA using sequencing
Isolated plasmid DNA was sequenced for presence of the insert without any mutations
using Seqlab (Go¨ttingen).
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Cloning of S. cerevisiae Chd1
A vector encoding full-length S. cerevisiae Chd1 was obtained through the MRC PPU
Reagents and Services facility (MRC PPU, College of Life Sciences, University of Dundee,
Scotland). The vector was used as a PCR template for cloning Chd1 into a modified
pFastBac vector via ligation independent cloning (LIC) [a gift of Scott Gradia, UC Berkeley,
vector 438-C (Addgene: 55220)]. The construct contains an N-terminal 6x His tag followed
by a maltose binding protein (MBP) tag and a tobacco etch virus protease cleavage site.
Cloning of S. cerevisiae FACT
gBlocks encoding Trichoplusia ni codon-optimized Spt16 and Pob3 were designed using
Integrated DNA Technologies (IDT) Codon Optimization Tool and synthesized by IDT.
Two gBlocks encoding the N- and C-terminal part of Spt16 were cloned into vector 438-C
using CPEC (Quan and Tian, 2011). The gBlock encoding Pob3 was cloned into vector
438-A (Addgene: 55218) using LIC. Combination of Spt16 and Pob3 into a single vector was
achieved by using successive rounds of LIC. Each subunit is preceded by a PolH promoter
and followed by a SV40 termination site. Spt16 has an N-terminal 6x His tag, followed by
a maltose binding protein (MBP) tag, and a tobacco etch virus protease cleavage site.
2.2.2 Bacmid preparation
Purified plasmids (500 ng) were electroporated into DH10EMBacY (Geneva Biotech, Geneva,
Switzerland) cells to generate bacmids containing full-length Chd1 or FACT constructs.
Bacmids were prepared from positive clones using blue/white selection, and alkaline ly-
sis followed isopropanol precipitation. V0 and V1 virus productions were performed as
described (Vos et al., 2016).
2.2.3 Insect cell expression
600 mL of Hi5 cells grown in ESF-921 media (Expression Systems, Davis, CA, United
States) were infected with 300 µL of V1 virus for protein expression. The cells were grown
for 48-72 hrs at 27 °C. Cells were harvested by centrifugation (238 xg, 4 °C, 30 min) and
resuspended in lysis buffer (300 mM NaCl, 20 mM Na·HEPES pH 7.4, 10% glycerol (v/v),
1 mM DTT, 30 mM imidazole pH 8.0, 0.284 µg/ml leupeptin, 1.37 µg/ml pepstatin A,
0.17 mg/ml PMSF, 0.33 mg/ml benzamidine). The cell resuspension was snap frozen and
stored at -80 °C.
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2.2.4 Protein purifications and related techniques
All protein purifications were performed at 4 °C, unless stated otherwise. Purified proteins
were aliquoted, snap-frozen in liquid nitrogen and stored at -80 °C unless stated otherwise.
Protein concentration determination
Absorption coefficients of proteins and protein complexes were determined by their primary
amino acid sequence and the ExPasy ProtParam tool at 280 nm. Protein concentration
were determined by measuring the absorption at 280 nm using a NanoDrop-200 spec-
trophotometer (Thermo Scientific). The calculated absorption coefficient was applied to
give the final protein concentration.
SDS-PAGE
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was used to ana-
lyze protein samples. Before SDS-PAGE, protein samples were mixed with 5× LDS sample
buffer (Invitrogen). Appropriate amounts of sample were loaded onto a 4-12 % NuPAGE
Bis-Tris gradient gel with 10 or 15 wells (Invitrogen). A protein standard was used to in-
dicate molecular weights (PageRuler Prestained Protein Ladder, Thermo Scientific). Gels
were run in 1× MES SDS Running Buffer (Invitrogen) at 200 V for 30-40 minutes. Gels
were subsequently stained with InstantBlue (expedeon) and imaged using a scanner (Epson
Perfection V700 Photo).
X. laevis histone purification
X. laevis histones were expressed and purified as described previously (Luger et al., 1999;
Dyer et al., 2004). Briefly, inclusion bodies were resuspended by using a manual Dounce
tissue grinder (Sigma-Aldrich). Histones were aliquoted, flash-frozen, lyophilized, and
stored at -80 °C prior to use. Lyophilized histones were resuspended in unfolding buffer
(7 M guanidine hydrochloride, 20 mM Tris-HCl pH 7.5, 10 mM DTT) to a concentration
of 1.5 mg/mL. H2A, H2B, H3, and H4 were then combined at a molar ratio of 1.2:1.2:1:1.
The sample was incubated on ice for 30 minutes before it was dialyzed against 3 x 600
mL refolding buffer (2 M NaCl, 10 mM Tris-HCl pH 7.5, 1 mM EDTA pH 8, 5 mM
β-mercaptoethanol) for a total of 18 hours at 4 °C. Dialyzed sample was recovered and
applied to a GE S200 16/600 pg size exclusion column, pre-equilibrated in refolding buffer.
Peak fractions containing histone octamer were pooled and concentrated to 30 µM.
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S. cerevisiae Chd1 purification
Protein purifications were performed at 4 °C. Frozen cell pellets were thawed and lysed by
sonication. Lysates were cleared by centrifugation (18,000 xg, 4 °C, 30 min) and ultracen-
trifugation (235,000 xg, 4 °C, 60 min). The supernatant containing Chd1 was filtered using
0.8 µm syringe filters (Millipore) and applied to a GE HisTrap HP 5 mL (GE Healthcare,
Little Chalfont, United Kingdom), pre-equilibrated in lysis buffer. After sample applica-
tion, the column was washed with 10 CV lysis buffer, 5 CV high salt buffer (1 M NaCl, 20
mM Na·HEPES pH 7.4, 10% glycerol (v/v), 1 mM DTT, 30 mM imidazole pH 8.0, 0.284
µg/mL leupeptin, 1.37 µg/mL pepstatin A, 0.17 mg/mL PMSF, 0.33 mg/mL benzami-
dine), and 5 CV lysis buffer. The protein was eluted with a gradient of 0-100% elution
buffer (300 mM NaCl, 20 mM Na·HEPES pH 7.4, 10% glycerol (v/v), 1 mM DTT, 500 mM
imidazole pH 8.0, 0.284 µg/mL leupeptin, 1.37 µg/ml pepstatin A, 0.17 mg/ml PMSF, 0.33
mg/ml benzamidine). Peak fractions were pooled and dialyzed for 16 hours against 600 mL
dialysis buffer (300 mM NaCl, 20 mM Na·HEPES pH 7.4, 10% glycerol (v/v), 1 mM DTT,
30 mM imidazole) in the presence of 2 mg His6-TEV protease. The dialyzed sample was
applied to a GE HisTrap HP 5 mL. The flow-through containing Chd1 was concentrated
using an Amicon Millipore 15 ml 50,000 MWCO centrifugal concentrator and applied to
a GE S200 16/600 pg size exclusion column, pre-equilibrated in gel filtration buffer (300
mM NaCl, 20 mM Na·HEPES pH 7.4, 10 % (v/v) glycerol, 1 mM DTT). Peak fractions
were concentrated to 100 µM, aliquoted, snap frozen, and stored at -80 °C. Typical yields
of S. cerevisiae Chd1 from 1.2 L of insect cell culture are 7-10 mg.
S. cerevisiae FACT purification
FACT was purified as described for Chd1, with minor modifications. After dialysis, the
sample was applied to tandem GE HisTrap HP 5 mL, GE HiTrap Q 5 mL columns. After
washing with 5 CV of dialysis buffer, the HisTrap was removed. FACT was eluted from
the HiTrap Q 5 mL by applying a gradient of 0-100% high salt buffer (1 M NaCl, 20
mM Na·HEPES pH 7.4, 10 % (v/v) glycerol, 1 mM DTT, 30 mM imidazole pH 8.0).
Peak fractions were pooled and applied to a GE S200 16/600 pg size exclusion column.
Pure fractions containing full-length FACT were concentrated as described above to a
concentration of 60 µM, aliquoted, flash frozen, and stored at -80 °C. Typical preparations
yield 10-15 mg of full-length S. cerevisiae FACT (Spt16 + Pob3) from 1.2 L of insect cell
culture.
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S. cerevisiae Paf1C purification
S. cerevisiae Paf1C (ΔCtr9-913) was expressed as described previously (Xu et al., 2017).
Combined cell pellets were resuspended in lysis buffer. The cell resuspension was lysed by
sonication and centrifuged (27,000 ×g, 30 min, 4 °C). The supernatant was filtered using a
0.8 µ syringe filter and applied to a GE HisTrap HP 5 mL (GE Healthcare), pre-equilibrated
in lysis buffer. The column was washed with lysis buffer for 5 CV, denatured protein wash
buffer for 5 CV, and lysis buffer for 5 CV. The protein of interest was then eluted using Ni
Elution buffer. The elution was collected in a 50 mL falcon. The conductivity of the sample
was then adjusted to the same conductivity as a HiTrap SP Buffer 0 mixture with 3.5 %
(v/v) of HiTrap SP Buffer 2000 using HiTrap SP Buffer 0. The diluted sample was then
applied to a HiTrap SP HP 5 mL (GE Healthcare) and washed for 40 CV with a HiTrap
SP Buffer 0 mixture with 3.5 % (v/v) of HiTrap SP Buffer 2000. Elution was achieved by
applying a gradient from 3.5 % (v/v) HiTrap SP Buffer 2000 to 40 % (v/v) HiTrap SP
Buffer 2000. Fractions were collected and the presence of Paf1C complex was monitored by
SDS-PAGE. Fractions containing Paf1C were pooled and concentrated (Amicon Millipore
15 ml 50,000 MWCO centrifugal concentrator). The concentrated sample was applied to a
Superose 6 10/300 (GE Healthcare), pre-equilibrated in gel filtration buffer. Peak fractions
were analyzed using SDS-PAGE. Fractions with stoichiometric amounts of all subunits of
Paf1C were subsequently concentrated. The concentrated sample containing the whole
Paf1C was aliquoted, snap-frozen and stored at -80 °C.
S. cerevisiae Rpb4/7 purification
S. cerevisiae Rpb4/7 was expressed in BL21-Codon Plus(DE3)-RIL cells. Cells were har-
vested and resuspended in 50 mL of Rpb4/7 freezing buffer per 2 L of culture. The cells
were lysed by sonication. The lysate was centrifuged (30 min, 27,000 ×g, and 4 °C).
The centrifugation was repeated once and the supernatant was pooled. The pooled sam-
ple was applied to 6 mL Ni-NTA resin, pre-equilibrated in Buffer 0. The Ni-NTA resin
was washed with salt buffer (3 CV), Buffer10 (3 CV), Buffer20 (3 CV), and Buffer 50 (3
CV). The sample was subsequently eluted using Buffer200 over 6 column volumes. The
conductivity of the elution sample was adjusted to the conductivity of SourceQ0. The
sample was filtered using a 0.22 µm sterile filter unit. The filtered protein sample was
applied to a MonoQ 10/100 column (GE Healthcare), pre-equilibrated in a mixture of 95
% SourceQ0 and 5 % SourceQ2000. The column was washed for 2 CV with a mixture of
95 % SourceQ0 and 5 % SourceQ2000. Elution was performed via a linear gradient over
10 column volumes from 95 % SourceQ0 and 5 % SourceQ2000 to 100 % SourceQ2000.
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The peak elution was monitored using SDS-PAGE. The fractions containin Rpb4/7 were
concentrated using an Amicon Millipore 15 ml 10,000 MWCO centrifugal concentrator
and applied to a pre-equilibrated GE Superdex 75 10/300. Fractions were collected and
analyzed by SDS-PAGE. Peak fractions with Rpb4/7 were concentrated with an Amicon
Millipore 15 ml 10,000 MWCO centrifugal concentrator. Protein concentration was esti-
mated as described. The protein was subsequently aliquoted, flash-frozen and stored at
-80 °C.
S. cerevisiae RNA polymerase II purification
S. cerevisiae cells of the BJ5464 strain were lysed using bead beaters (Hamilton Beach
Brands, Inc.). 200 mL of cell suspension were filled into a bead beater metal chamber. An
equal amount of glass beads with a diameter of 0.5 mm were added to the cell suspension.
The cell lysis was carried out at 4-8 °C for a total of 90 minutes. The bead beater were
cycled in the following pattern: 30 s ON, 90 s OFF for 90 minutes. The metal chambers
of the bead beater were constantly cooled using an ice-salt mixture. The resulting cell
lysate was subsequently centrifuged for 30 min at 13,689 ×g and 4 °C. Centrifugation
was repeated once. The supernatant was ultracentrifuged at 76,221 ×g and 4 °C for 90
min in a Ti 45 rotor (Beckman-Coulter). The supernatant was pooled and an ammonium
sulphate precipitation was performed by addition of 50 % (w/v) ammonium sulphate under
constant stirring. After an incubation time of 12 hours, the protein sample was centrifuged
at 34,200 ×g and 277 K for 45 minutes. The centrifugation was repeated once, and the
supernatant was discarded. The resulting ammonium sulphate pellet was resuspended in
140 mL HSB 0/7 per 100 g of ammonium sulphate pellet. The conductivity was measured
and adjusted to the conductivity of the HSB1000/7 buffer. The conductivity adjusted
sample was applied to Ni-NTA resin (Qiagen), pre-equilibrated in HSB1000/7 and 3 CV
of Ni Buffer7. Rpb3 His-tagged Pol II was eluted with Ni buffer 200 and elution fractions
were collected. The conductivity of the elution sample was adjusted to the conductivity of
Mono Q 150. The sample was subsequently applied to a pre-equilibrated MonoQ 10/100
column (GE Healthcare). Pol II was eluted using a gradient over 12 column volumes from
a salt concentration of 150 mM KOAC to 1500 mM KOAc at a flow rate of ∼2 mL/min.
Fractions containing Pol II were collected in 1 mL fractions in 96-well blocks. Presence
of Pol II was monitored by SDS-PAGE. Recombinantly expressed and purified Rpb4/7
was added at a two-fold molar excess and incubated for 40 min to form a homogeneous
12-subunit RNA polymerase II complex. The sample was applied to a Superose 6 10/300
size exclusion column (GE Healthcare), which was pre-equilibrated in gel filtration buffer.
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Fractions were collected in 96-well blocks with a 0.5 mL fraction size. Presence of Pol
II was again monitored by SDS-PAGE. The peak elution containing Pol II was pooled
and concentrated to a final concentration of 4 mg/mL. The sample was then aliquoted,
snap-frozen in liquid nitrogen and stored as described.
Mass spectrometry
Proteins were subjected to SDS-PAGE. Individual protein bands were selected for mass
spectrometric determination and processed by the mass spectrometric core facility at the
MPI for Biophysical Chemistry (Go¨ttingen, Germany). Results were analyzed using the
software Scaffold 4.
2.2.5 Preparation of DNA for nucleosome reconstitutions
DNA fragments for nucleosome reconstitution were generated by PCR, essentially as de-
scribed previously (Maskell et al., 2015). A vector containing the Widom 601 sequence
was used as a template for PCR. In-house expressed and purified Phusion polymerase was
used for the PCR reaction with two primers (Forward: CGC TGT TTT CGA ATT TAC
CCT TTA TGC GCC GGT ATT GAA CCA CGC TTA TGC CCA GCA TCG TTA ATC
GAT GTA TAT ATC TGA CAC GTG CCT, Reverse: ATC AGA ATC CCG GTG CCG
AG). The PCR program had the following steps: 1. 98° for 1 min, 2. 98 °C for 10 sec, 3.
72 °C for 45 sec, cycle between step 2 and 3 for 35 times, 4. 72 °C for 10 min, 5. Pause
at 5 °C. PCR products were pooled from three 48-well PCR plates (100 µL per well). The
products were ethanol precipitated and resuspended in 1 mL TE buffer (10 mM Tris pH
8.0, 1 mM EDTA pH 8.0). The resuspended DNA was applied to a ResourceQ 6 mL (GE
Healthcare) and eluted with a gradient from 0-100 % TE high salt buffer (10 mM Tris pH
8.0, 1 M NaCl, 1 mM EDTA pH 8.0). Peak fractions were analyzed on a 1 % (v/v) TAE
agarose gel and fractions containing the desired DNA product were pooled. The sample
was ethanol precipitated, resuspended in 200 µL TE buffer, and stored at -20° prior to use.
2.2.6 Preparation of reconstituted nucleosomes
Nucleosome reconstitution was performed as described (Dyer et al., 2004), with minor
modifications. Histone octamer and DNA were mixed at a 1:1 molar ratio in 2 M KCl,
and transferred to Slide-A-Lyzer MINI Dialysis Units 20,000 MWCO (Thermo Scientific,
Waltham, MA, United States). The sample was gradient dialyzed against low salt buffer
(30 mM KCl, 20 mM Na·HEPES pH 7.5, 1 mM EDTA pH 8, 1 mM DTT) over 18 hours.
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The sample was dialyzed for another four hours against low salt buffer, recovered, and
stored at 4 °C. Quantification of the reconstituted nucleosome was achieved by measuring
absorbance at 280 nm. Molar extinction coefficients were determined for protein and
nucleic acid components and were summed to yield a molar extinction coefficient for the
reconstituted NCP.
2.2.7 Preparation of nucleosomal complexes
To prepare a nucleosome-Chd1-FACT-Paf1C complex, FACT, Chd1, and Paf1C were mixed
at a molar ratio of 1:1.2:1.4 and incubated for 10 minutes. Zero monovalent salt buffer
(2 mM MgCl2, 20 mM Na·HEPES pH 7.5, 5 % (v/v) glycerol , 1 mM DTT) was added
within 6 minutes to achieve a final monovalent salt concentration of 30 mM. Reconsituted
NCP was added at a 0.5 molar ratio of the FACT concentration. The sample was incu-
bated for 10 minutes, centrifuged (21,000 ×g, 4 °C, 10 min), and applied to a Superose 6
Increase 3.2/300 column equilibrated in gel filtration buffer (30 mM NaCl, 2 mM MgCl2,
20 mM Na·HEPES pH 7.5, 5 % (v/v) glycerol, 1 mM DTT). Peak fractions were pooled,
ADPÂůBeF3 was added to a concentration of 1 mM ADP and 3 mM BeF3-, and incubated
for 10 minutes. The sample was cross-linked with 0.1 % (v/v) glutaraldehyde, incubated
for 10 minutes on ice. The cross-linking reaction was quenched for 10 min using a concen-
tration of 90 mM Tris-HCl (pH 7.9), 9 mM lysine and 9 mM aspartate. The sample was
transferred to a Slide-A-Lyzer MINI Dialysis Unit 20,000 MWCO (Thermo Scientific), and
dialyzed for 6 hours against 600 mL dialysis buffer (30 mM NaCl, 2 mM MgCl2, 20 mM
Na·HEPES pH 7.4, 1 mM DTT).
2.2.8 Cryo-EM and image processing
Cryo-EM
The nucleosome-Chd1-FACT-Paf1C complex sample was applied to R2/2 gold grids (Quan-
tifoil). The grids were glow-discharged for 45 seconds before sample application of 2 µL
on each side of the grid. The sample was subsequently blotted for 8.5 seconds and vitrified
by plunging into liquid ethane with a Vitrobot Mark IV (FEI Company, Hillsboro, OR,
United States) operated at 4 °C and 100 % humidity. Cryo-EM data was acquired on a
FEI Titan Krios transmission electron microscope (TEM) operated at 300 keV, equipped
with a K2 summit direct detector (Gatan, Pleasanton, CA, United States). Automated
data acquisition was carried out using FEI EPU software at a nominal magnification of
105,000x. Image stacks of 40 frames were collected in counting mode over 10s. The dose
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rate was 3 e- per A˚ngstro¨m2 per second for a total dose of 30 e- A˚-2. A total of 3806 image
stacks were collected.
Image processing
Frames were stacked and subsequently processed with MotionCor2 (Zheng et al., 2017).
CTF correction was performed with Gctf (Zhang, 2016). Image processing was performed
with RELION 2.0.4 (Scheres, 2012; Kimanius et al., 2016), unless noted otherwise. Post-
processing of refined models was performed with automatic B-factor determination in
RELION. Particles were picked using projections of an initial reconstruction (∼400,000
particles, FEI Falcon 2, not shown), yielding 990,020 particle images. Particles were ex-
tracted with a box size of 2242 pixel, normalized, and screened using iterative rounds of
reference-free 2D classification, yielding a total of 773,326 particles. Particle images were
sub-divided into three batches and processed individually. Using a 40 A˚ low-pass filtered
model from an initial reconstruction (not shown), I performed iterative rounds of hierar-
chical 3D classification with image alignment as outlined in (Figure 8. The three particle
image batches were subsequently merged, re-extracted with a box size of 2402 pixel and
subjected to another round of 3D classification with image alignment. The best two classes
were combined and subjected to a 3D refinement with a mask that encompasses the entire
NCP-Chd1 complex. The NCP-Chd1 reconstruction was obtained from 67,032 particles
with a resolution of 4.8 A˚(gold-standard Fourier shell correlation 0.143 criterion). The map
was sharpened with a B-factor of -204 A˚2. Local resolution estimates were determined using
a sliding window of 403 voxels as previously described (Plaschka et al., 2016). Resolutions
for individual Chd1 domains were determined by masking the respective regions and per-
foming B-factor sharpening (gold-standard Fourier shell correlation 0.143 criterion) using
RELION.
Model building
Crystal structures of the X. laevis nucleosome with Widom 601 sequence (Vasudevan
et al., 2010) (PDB code 3LZ0), the S. cerevisiae Chd1 DNA-binding domains13 (PDB
code 3TED), and S. cerevisiae Chd1 core (Hauk et al., 2010) (double chromodomain and
ATPase motor, PDB code 3MWY) were placed into the electron density using UCSF
Chimera (Pettersen et al., 2004). The individual Chd1 domains (SANT, SLIDE, double
chromodomain, ATPase lobe 1, ATPase lobe 2) were fitted as rigid bodies. Residues 842-
922 were removed from the double chromodomain-ATPase motor structure (PDB code
3MWY) due to weak density. We did not observe assignable density for the CHCT do-
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main of Chd1. We did not assign weak density near H3 (residues 46-56), and H2A (residues
56-71). Extranucleosomal DNA, nucleosomal DNA from SHL -7 to SHL -5, and the H4
N-terminal tail residues 16-20 were built using COOT (Emsley et al., 2010). Three rounds
of flexible fitting were performed with vmd (Humphrey et al., 1996) and MDFF (Trabuco
et al., 2008), resulting in good fits of the electron density. Secondary structure restraints
were applied and the model was real-space refined against the post-processed EM map
using PHENIX48. ADP·BeF3- was built by superpositioning ATP-γ-S from the inactive
Chd1 structure (PDB code 3MWY) onto our model, and replacing the ATP analogue
with ADP·BeF3- (PDB code 3ICE) (Thomsen and Berger, 2009). BeF3- was modeled in
a tetrahedral conformation for simplicity but is likely planar when it mimics part of the
pentavalent transition state of ATP hydrolysis. While ADP is remarkably well-resolved
at the given resolution, BeF3- has weaker density and was modelled based on previous
structural data from other ATPases. R804 and R807 were fitted manually. The complete
structure was geometry-optimized with PHENIX. Figures were generated using PyMol
(Schrodinger„ LLC, 2015) and UCSF Chimera (Pettersen et al., 2004). Electron density
was shown for the local resolution filtered map, if not stated otherwise.
2.2.9 Crystallography and data analysis of crystallographic data
Crystallography of Pol II EC
12-subunit Pol II (4.1 mg/mL) was incubated with a 1.5-fold molar excess of nucleic acid
scaffold containing the 3d-Napht-A analog and 5-Br-U. The sample was incubated for
20 min on ice before crystallization by hanging drop vapor diffusion using 4-7 % PEG
6000, 200 mM ammonium acetate, 300 mM sodium acetate, 50 mM HEPES pH 7.0 and
5 mM TCEP as reservoir solution. Crystals were grown for 4-8 days, cryo-protected in
mother solution supplemented with 22 % glycerol and nucleic acid scaffold. Crystals were
incubated overnight at 8 °C before they were harvested and flash-cooled in liquid nitrogen.
Data collection of crystallographic data
Diffraction data were collected at beamline X06SA of the SLS (Swiss Light Source, Villigen,
Switzerland) or beamline P13 at the Deutsches Elektronensynchrotron (DESY, Hamburg,
Germany). The native data set was collected at a wavelength of 0.976 A˚. The bromine
peak data set was collected at a wavelength of 0.919 A˚.
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Data processing and model building
Diffraction images were processed with XDS. The structure was solved with molecular
replacement using a 12-subunit Pol II structure (PDB 3HOX) without nucleic acids. Re-
finement was performed using Phenix.Refine (Adams et al., 2010). Refinement statistics are
summarized in Supplementary Table 1. The final model was analyzed using MolProbity
45. 92 % of residues were in Ramachandran plot favored regions, 7.1 % in allowed re-
gions. 0.9 % Ramachandran outliers were observed. Figures were generated using PyMOL
(Schrodinger„ LLC, 2015).
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3 Results & Discussion
3.1 Nucleosome-Chd1 structure and implications for
chromatin remodelling
Results presented in this section are currently in the process of being published (in press):
Lucas Farnung, Seychelle M. Vos, Christoph Wigge, Patrick Cramer. (2017) Nucleosome-
Chd1 structure and implications for chromatin remodelling. Nature. doi: 10.1038/na-
ture24046
The results presented in this section are based on the cited publication. Authors con-
tributions are stated in the Publications chapter.
3.1.1 Abstract
Chromatin remodelling factors change nucleosome positioning and facilitate DNA tran-
scription, replication, and repair (Narlikar et al., 2013). The conserved remodelling factor
Chd (Hauk and Bowman, 2011) can shift nucleosomes and induce a regular nucleosome
spacing (Lieleg et al., 2015; Hughes and Rando, 2015; Lusser et al., 2005). Chd1 is required
for RNA polymerase II passage through nucleosomes (Skene et al., 2014) and for cellular
pluripotency (Gaspar-Maia et al., 2009).
Chd1 contains the DNA-binding domains SANT and SLIDE, a bilobal motor domain
that hydrolyses adenosine triphosphate (ATP), and a regulatory double chromodomain.
Here we report the cryo-electron microscopy (cryo-EM) structure of Chd1 from the yeast
S. cerevisiae bound to a nucleosome at a resolution of 4.8 A˚. Chd1 detaches two turns of
DNA from the histone octamer and binds between the two DNA gyres in a state poised
for catalysis. The SANT and SLIDE domains contact detached DNA around superhelical
location (SHL) -7 of the first DNA gyre. The ATPase motor binds the second DNA gyre at
SHL +2 and is anchored to the N-terminal tail of histone H4 as in a recent nucleosome-Snf2
ATPase structure (Liu et al., 2017).
Comparison with published results reveals that the double chromodomain swings to-
wards nucleosomal DNA at SHL +1, resulting in ATPase closure (Nodelman et al., 2017).
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The ATPase can then promote translocation of DNA towards the nucleosome dyad, thereby
loosening the first DNA gyre and remodelling the nucleosome. Translocation may involve
ratcheting of the two lobes of the ATPase, which is trapped in a pre- or post-translocated
state in the absence (Liu et al., 2017) or presence, respectively, of transition state-mimicking
compounds.
3.1.2 NCP-Chd1-FACT-Paf1C complex
To investigate how RNA polymerase II transcribes through chromatin, we prepared fac-
tors that facilitate chromatin transcription in the yeast S. cerevisiae (Methods). These
included the chromatin-remodelling enzyme Chd1 (chromodomain-helicase-DNA binding
protein 1) (Figure 6), the histone chaperone FACT (facilitates chromatin transcription) and
the transcription elongation factor Paf1C (polymerase-associated factor 1 complex). We
formed a complex of these factors in the presence of the transition state-mimicking adduct
ADP·BeF3 and a nucleosome with DNA comprising the Widom 601 sequence (Lowary and
Widom, 1998) and 63 base pairs (bp) of extranucleosomal DNA (Methods).
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Figure 6: Chd1 domain architecture. Residues at domain boundaries are indicated.
3.1.3 NCP-Chd1 structure at 4.8 A˚
Cryo-EM analysis revealed nucleosome-Chd1 particles that had lost FACT and Paf1C
(Figure 8, A1). The resulting reconstruction of the nucleosome-Chd1 complex at an overall
resolution of 4.8 A˚ revealed protein secondary structure (Figure A2, Table A1). Crystal
structures of the nucleosome (Vasudevan et al., 2010; Lowary and Widom, 1998) and Chd1
domains (Hauk et al., 2010; Sharma et al., 2011) were unambiguously placed into the
density. Only a minor, unassigned density remained that was located near histones H3
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(residues 46-56) and H2A (residues 56-71) and may arise from a C-terminal domain in
Chd1 (Mohanty et al., 2016). A detailed structure was obtained after flexible fitting and
real-space refinement.
The structure reveals an altered nucleosome with one engaged Chd1 molecule (Figure
7). Two turns of nucleosomal DNA at SHL -5 to -7 are detached from the histone octamer.
This alters the trajectory of extranucleosomal DNA by ∼ 60°and breaks DNA interactions
with histones H2A, H2B, and H3 (Figure 9).
The ability of Chd1 to detach DNA depends on the presence of an ATP analogue or
ADP· BeF3, indicating that our structure trapped Chd1 in a state poised for activity. The
histone octamer is unaltered compared to the free nucleosome, whereas it adopts an altered
conformation in a nucleosome-ACF remodelling complex with ADP· BeF3 (Sinha et al.,
2017) (Figure A3f).
Chd1 binds between extranucleosomal DNA and the second DNA gyre at SHL +2
(Figure 11), 10), consistent with lower-resolution information (Sundaramoorthy et al.,
2017). Chd1 domains assemble between the two DNA gyres and form multiple DNA
interactions. The SANT and SLIDE domains contribute to Chd1 affinity for the nucleosome
(McKnight et al., 2011) and contact the first turn of extranucleosomal DNA in a way that
was observed for free DNA (Sharma et al., 2011). The ATPase engages with DNA at SHL
+2, consistent with the structure of the related Snf2 ATPase bound to the nucleosome (Liu
et al., 2017) and with biochemical data (Nodelman et al., 2017; McKnight et al., 2011). The
double chromodomain contacts DNA at SHL +1 (Figure 12) and binds between the SANT
domain and ATPase lobe 1. The structure is incompatible with binding of linker histone H1
(Bednar et al., 2017), explaining why H1 can repress Chd1-dependent remodelling (Lusser
et al., 2005).
The ATPase motor adopts a closed conformation with the ADP·BeF3 adduct bound
between lobes 1 and 2 (Figure 15). Compared to the free Chd1 structure (Hauk et al., 2010),
lobe 2 rotates by ∼40° towards lobe 1. This rotation closes the active site and positions the
catalytic arginine ’fingers’ in lobe 2 (R804 and R807) close to the ATP-binding site (Figure
13) (Gu and Rice, 2010; Sengoku et al., 2006). One of these arginine fingers is mutated in
human CHD1 in prostate cancers (Huang et al., 2012). These observations indicate that
the structure trapped Chd1 in a functional state poised for catalysis.
The ATPase motor interacts extensively with DNA (Figure 10). Based on biochemical
and structural observations (Gu and Rice, 2010; Singleton et al., 2007), we define the
’tracking strand’ as the DNA strand running in the 5’ to 3’ direction from SHL +2 towards
the histone octamer dyad. Lobe 1 contacts the tracking strand backbone with three protein
regions containing ATPase motifs Ia and Ic, and with a loop (residues 457-461) located
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Figure 7: Three views of the NCP-Chd1 structure. a-c. Chd1 domains are colored as in
Fig X. H2A, H2B, H3, H4, tracking strand, and guide strand are in yellow, red, light blue,
green, dark blue, and cyan, respectively. The histone octamer dyad axis is indicated as
black line or black oval circle. SHL, superhelical location.
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Figure 8: Sorting and classification tree used to reconstruct the nucleosome-Chd1 particle
at 4.8 A˚ resolution. Steps 1 and 2 of batch 1 global classification are shown representatively
for all three batches.
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Figure 9: Detachment of nucleosomal DNA from the histone octamer at SHL -7 to -5.
Extranucleosomal DNA rotates by 60° with respect to its location in the absence of Chd1
(orange, modelled by extending nucleosomal DNA with B-DNA). The position of Chd1 is
indicated in grey color.
between motifs Ia and Ib. The lobe 1 regions formed by motifs IIa and III contact the
complementary ’guide’ DNA strand. Lobe 2 interacts with the tracking strand via loops
formed by motifs IV, IVa, and V. Residue Trp793 in motif Va inserts into the minor groove
and contacts the guide strand backbone (Figure 14). These ATPase-DNA interactions
resemble the ’primary’ interactions in a nucleosome-Snf2 complex (Liu et al., 2017) and
interactions observed in a distantly related ATPase-DNA complex (Du¨rr et al., 2005). The
interactions support the model that Chd1 translocates along the DNA minor groove from
SHL +2 away from the octamer dyad, thereby moving DNA towards the dyad (Narlikar
et al., 2013; Nodelman et al., 2017; Saha et al., 2005).
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Figure 10: Primary ATPase-DNA interactions. Location of ATPase motifs on lobe 1
and lobe 2 are highlighted in red and green, respectively. The view is from the center of
the histone octamer onto nucleosomal DNA. DNA register is indicated by numbering next
to DNA bases. Color code is as in Figure 7. ADP·BeF3 is shown as grey spheres. The
model of lobe 2 in the pre-translocated position (grey) was derived from superposition of
the nucleosome-Snf2 structure (PDB code 5X0Y) (Liu et al., 2017).
3.1.4 Regulation of the Chd1 ATPase motor activity by the dou-
ble chromodomain
The structure also reveals the basis for ATPase activation by nucleosome binding. In the
absence of the nucleosome, ATPase lobe 2 is sequestered in an open conformation by the
’chromo-wedge’, an acidic region in the double chromodomain (Hauk et al., 2010). In the
presence of the nucleosome, the double chromodomain swings by 15°and binds nucleosomal
DNA. The chromo-wedge contacts the DNA backbone at SHL +1 (Figure 12) using a region
that contains cancer mutations in the human homologue CHD4. Thus, binding of Chd1 to
nucleosomal DNA induces swinging of the double chromodomain that releases lobe 2 and
allows for ATPase closure and activation. Chd1 recognizes bent nucleosomal DNA because
42
3. Results & Discussion
Primary DNA interactions (SHL +2)
SANT/SLIDE-
DNA interactions
(Extranucleosomal DNA)
Secondary
DNA interactions
(SHL -6.5)
Contact of chromo-wedge 
with DNA at SHL +1.
Figure 11: Overview of Chd1-DNA interactions. Primary and secondary interactions of
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Figure 12: Contact of chromo-wedge with DNA at SHL +1. Basic residues important
for DNA interaction are highlighted.
free DNA only weakly activates the ATPase (Hauk et al., 2010), and straight B-DNA would
clash with the double chromodomain (Figure 16).
Interactions of the double chromodomain with other Chd1 domains may compensate
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Figure 13: ADP·BeF3 binds in the active site of the Chd1 ATPase motor. Electron
density is shown for ADP·BeF3, motif I (Walker A, P-loop, residues 403-410), motif II
(Walker B, residues 510-515), and the arginine fingers (R804 + R807). Motifs I and II are
shown in ribbon representation. ADP·BeF3 and the arginine finger residues are shown as
sticks. Density for ADP is strong, whereas density for BeF3- is weaker and thus we cannot
formally rule out that BeF3- is not bound or shows only partial occupancy.
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24
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Figure 14: Contact of W793 with the phosphate backbone of the guide strand at SHL
+2. Electron density is shown as a grey mesh. Side chain of W793 is shown as a stick
representation.
for the loss of histone-DNA contacts upon detaching nucleosomal DNA. The double chro-
modomain binds the SLIDE domain as predicted (Nodelman et al., 2017) (Figure 18).
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Figure 15: Chd1 structural changes and ATPase activation. a. Swinging of double
chromodomain (open state, light pink; closed state, purple) onto DNA liberates ATPase
lobe 2 (grey). The structure of free Chd1 in its inactive state (Hauk et al., 2010) (PDB
code 3MWY) was placed by superimposing ATPase lobe 1 (orange). In the inactive state,
the chromo-wedge binds to a basic patch on lobe 2. View as in Figure 7. b. ATPase closure
and activation. Lobe 2 (sea green) rotates by ∼40° to allow for binding of ADP·BeF3 (grey
spheres). BeF3- was modeled in a tetrahedral conformation for simplicity but is likely
planar when it mimics part of the pentavalent transition state of ATP hydrolysis.
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Figure 16: Modeling linear B-DNA (orange) onto the ATPase motor in the nucleosome-
Chd1 structure leads to a clash with the double chromodomain (purple). B-DNA was
superimposed onto nucleosomal DNA at SHL +2.
It also binds and buttresses lobe 1, which not only contacts SHL +2 but also detached
DNA around SHL -6 on the second DNA gyre (Figure 17). In particular, motif Ib and
residue 506 (between motifs Ic and II) bind the DNA backbone. These additional contacts
between the ATPase and the second DNA gyre resemble the ’secondary’ contacts in the
nucleosome-Snf2 complex (Liu et al., 2017).
3.1.5 Model for ATPase motor activity
Comparison of our structure with the nucleosome-Snf2 complex (Liu et al., 2017) suggests a
model for how ATP binding and hydrolysis result in DNA translocation. In the absence of
ATP (Liu et al., 2017), the ATPase is partially closed, whereas in the presence of ADP·BeF3
it is entirely closed (Figure 13). Superposition of lobe 1 in these two structures results in
different positions of lobe 2, which are offset along DNA by approximately one base pair
in the direction of translocation (Figure 10). Provided that ATPases move in steps of one
base pair (Singleton et al., 2007; Saikrishnan et al., 2009; Hopfner and Michaelis, 2007),
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Figure 17: Secondary DNA contacts of ATPase lobe 1. Contact of motif Ib with first
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these observations suggest that the conformational ’ratcheting’ between the ATPase lobes
underlies DNA translocation (Wigley and Bowman, 2017).
According to this translocation model, the ATPase first binds DNA in a partially closed
conformation (pre-translocation state). ATP binding then leads to complete closure of
the ATPase and lobe 2 movement, which triggers DNA translocation by one base pair
(post-translocation state). ATP hydrolysis then dissociates ADP and resets the ATPase
to the pre-translocated state at the new DNA position. We speculate that directional
translocation within this enzymatic cycle results from non-equivalent lobe 2 movements
during translocation and ATPase resetting.
The structure also reveals the basis for ATPase activation by nucleosome binding (Fig-
ure 15). In the absence of the nucleosome, ATPase lobe 2 is sequestered in an open
conformation by the ’chromo-wedge’, an acidic region in the double chromodomain (Fig-
ure 15a) (Hauk et al., 2010). In the presence of the nucleosome, the double chromodomain
swings by 15° and binds nucleosomal DNA (Figure 15b) (Nodelman et al., 2017). The
chromo-wedge contacts the DNA backbone at SHL +1 (Figure 12) using a region that
contains cancer mutations in the human homologue CHD4 (Le Gallo et al., 2012). Thus,
binding of Chd1 to nucleosomal DNA induces swinging of the double chromodomain that
releases lobe 2 and allows for ATPase closure and activation. Chd1 recognizes bent nucle-
osomal DNA because free DNA only weakly activates the ATPase (Hauk et al., 2010), and
straight B-DNA would clash with the double chromodomain (Figure 16).
3.1.6 Molecular interactions of Chd1 and histones
Our structure also reveals Chd1 interactions with histones. ATPase lobe 2 contacts highly
conserved residues in helix α 1 of histone H3. Lobe 2 also uses an acidic pocket to bind
to the basic N-terminal tail of histone H4 (Figure 19). This predicts that H4 acetylation
or methylation at residues K16 and K20, respectively, alter Chd1 binding. A similar lobe
2-H4 tail interaction is observed in the nucleosome-Snf2 complex (Liu et al., 2017), and
the H4-binding pocket is conserved in ISWI (Clapier et al., 2001), suggesting that H4 tail
binding is a general feature of remodelling enzymes.
3.1.7 Model for chromatin remodelling by Chd1
Our structural observations and published biochemical data (Nodelman et al., 2017; Sun-
daramoorthy et al., 2017; McKnight et al., 2011; Saha et al., 2005; Nodelman et al., 2016)
converge on a model for nucleosome remodelling by Chd1. Chd1 positions its ATPase
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Figure 19: Chd1 binds the N-terminal tail of histone H4 (green) with ATPase lobe 2
(surface representation coloured according to electrostatic surface potential; red, negative,
white, neutral, blue, positive). The view is the inverse of that in Figure 7, i.e. after a 180°
rotation.
motor at SHL +2 and uses a ratcheting cycle to move on the tracking strand in the 3’-5’
direction away from the octamer dyad. As Chd1 holds onto histones, this results in DNA
translocation towards the octamer dyad. Progression of the ATPase by one nucleotide per
catalytic event (Singleton et al., 2007; Saikrishnan et al., 2009; Hopfner and Michaelis,
2007) leads to a helical rotation of DNA. This may generate a short DNA region that is
slightly peeled away from the octamer surface. Propagation of this dissociated region would
reposition the octamer, consistent with proposed models (Narlikar et al., 2013; Clapier and
Cairns, 2009).
This model for nucleosome remodelling, however, does not explain how Chd1 centers
nucleosomes on a DNA fragment and how it induces a regular nucleosome spacing. One
possibility is that two Chd1 molecules act from opposite sides of the nucleosome to center
it by shifting it away from both DNA ends (Nodelman et al., 2017). Alternatively, a single
Chd1 molecule may center the nucleosome if the ATPase motor (McKnight et al., 2011)
could swing between two positions on the nucleosome. It is also possible that instead or
in addition the DNA-binding region can be repositioned as observed for SNF2h (Leonard
and Narlikar, 2015).
In conclusion, our structure of the nucleosome-Chd1 complex provides a framework
for understanding nucleosome remodelling and its coupling to other nuclear events. The
conservation of Chd1 domains across species and homologues indicates that our results
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are relevant for understanding all proteins of the CHD family. The high conservation of
the ATPase motor (Figure 20) further suggests that our results can inform mechanistic
analysis of other chromatin-remodelling factors, including those of the ISWI family (Yan
et al., 2016), which resemble Chd1 in domain architecture.
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Figure 20: Sequence alignment of ATPase regions in ScChd1 (356-883), ScIsw1 (177-
689), ScSnf2 (746-1270), HsChd4 (703-1233), DmMi-2 (707-1231), and SsoRad54 (423-
802). Arginine ’fingers’ of ScChd1 (R804+R807) are indicated and ATPase motifs are
underlined. Sequence coloured according to identity. Darker shades of blue indicate higher
conservation, whereas lighter shades of blue indicate less conservation. Alignment was
generated with MAFFT (Katoh and Standley, 2013) and visualized using JalView (Wa-
terhouse et al., 2009).
50
3. Results & Discussion
3.2 Mechanism of RNA polymerase II stalling by DNA
alkylation
Results presented in this section are in the process of being published:
Stefano Malvezzi*, Lucas Farnung*, Claudia Aloisi, Todor Angelov, Patrick Cramer,
Shana J. Sturla. (2017) Mechanism of RNA polymerase II stalling by DNA alkylation
PNAS. (accepted in principle)
The results presented in this section are based on the cited publication. Authors con-
tributions are stated in the Publications section. Abstract and introduction are given for
context. Experiments presented in the results section were performed by Lucas Farnung,
unless otherwise stated. Results that are part of the stated publication but were not
obtained by Lucas Farnung are found in the Appendix for context.
3.2.1 Abstract
Several anticancer agents form DNA adducts in the minor groove, interfering with DNA
replication and transcription, and inducing apoptosis. Therapeutic resistance can occur,
however, when cells are proficient in the removal of drug-induced damage. Acylfulvenes
are a class of experimental anticancer agents with a unique repair profile suggesting their
capacity to stall RNA polymerase (Pol) II and trigger transcription-coupled nucleotide
excision repair. Here we show how different forms of DNA alkylation impair transcription
by RNA PolÂăII in cells and with the isolated enzyme, and unravel a new mode of RNA
Pol II stalling that is due to alkylation of DNA in the minor groove. We incorporated a
model for acylfulvene adducts, the stable 3-deaza-3-methoxynaphtylethyl-adenosine analog
(3d-Napht-A), and smaller 3-deaza-adenosine analogs, into DNA oligonucleotides to assess
RNA Pol II transcription elongation in vitro. RNA Pol II was strongly blocked by a 3d-
Napht-A analog but bypassed smaller analogs. Crystal structure analysis revealed that
a DNA base containing 3d-Napht-A can occupy the +1 templating position and impair
closing of the trigger loop in the Pol II active center and polymerase translocation into
the next template position. These results show how RNA Pol II copes with minor groove
DNA alkylation and establish a mechanism for drug resistance.
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3.2.2 Introduction
The catalysis of transcription by RNA polymerase is fundamental to the viability of growing
cells. In conventional cancer chemotherapy, DNA damage products that interfere with
genomic processes initiate cell death. However, therapeutic resistance of cancer cells to
DNA alkylating agents may result when cells are proficient in the repair of drug-induced
damage (Salehan and Morse, 2013; Cirauqui et al., 2016; Yu et al., 2017).
Acylfulvenes (AFs) are a class of experimental anticancer drugs that appear to be
selectively repaired by the transcription-coupled sub-pathway of nucleotide excision repair
(TC-NER) (Jaspers et al., 2002; Koeppel et al., 2004; Otto et al., 2017). Thus, AF-induced
DNA adducts are preferentially removed from actively transcribed regions of the genome
but are largely ignored by global-genome repair. These findings suggest that the AF-DNA
adduct does not perturb the duplex structure, yet impedes the progress of RNA polymerase.
Understanding the chemical basis of how DNA alkylation stalls RNA polymerase to initiate
repair can provide key insight for the design of therapeutics less prone to failure due to
resistance.
AFs are semi-synthetic derivatives of the fungal sesquiterpene illudin S and alkylate
DNA in the minor groove (Gong et al., 2007), a common property for several anticancer
agents such as distamycins, lexitropsins, duocarmycins, and ecteinascidin 743, as well as
peptide-based minor groove binders (Hargrove et al., 2015). Hydroxymethylacylfulvene
(HMAF, irofulven) was tested previously in clinical trials for several cancers and is an-
ticipated to re-enter clinical trials with biomarker-driven patient stratification strategies.
Acylfulvenes are pro-drugs that are reductively activated by prostaglandin reductase 1
(PTGR1) to alkylate primarily position 3 of adenine (Figure B2a) (Gong et al., 2007). In-
hibition of DNA synthesis and capacity to induce cell cycle arrest of minor-groove alkylating
agents is attributed primarily to alkylation of DNA, and levels of 3-AF-A in AF-treated
cancer cells are proportional to cytotoxicity (Gong et al., 2007; Neels et al., 2007; Pietsch
et al., 2013; van Midwoud and Sturla, 2013; Woynarowski et al., 1997).
Cells have evolved various DNA repair functions, and large helix-distorting adducts are
often removed by the nucleotide excision repair (NER) pathway. NER is divided into two
sub-pathways: transcription coupled- (TC-) and global genome- (GG-) NER (Hanawalt,
2002). TC-NER-deficient human fibroblast cells are more sensitive to illudin S, AF and
HMAF compared to GG-NER-deficient human fibroblast cells, suggesting that TC-NER
selectively repairs AF adducts (Figure B2a) (Jaspers et al., 2002; Koeppel et al., 2004;
Otto et al., 2017). Moreover, siRNA-mediated down-regulation of TC-NER in a cancer
cell line greatly increased their sensitivity to AF, whereas down-regulation of GG-NER did
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not (Figure B2a) (Otto et al., 2017). Since AF adducts are selectively repaired by TCR
and ignored by GG-NER, a large portion of adducts that are not repaired in surviving
cells are expected to be a basis of the increased mutation frequency observed in cell lines
(Glatt et al., 2014). Indeed, error-prone bypass of minor groove modifications has been
characterized for certain translesion synthesis DNA polymerases (Malvezzi et al., 2017).
Finally, exposing a cancer cell line to UCN-01, a compound that inhibits Chk1, enabling
checkpoint evasion and reduction of NER function, increased sensitivity to AF. Moreover,
AF adducts persisted longer in co-treated cells (van Midwoud and Sturla, 2013; Jiang and
Yang, 1999). The repair and persistence profiles for AF-DNA adducts thus suggests that
the basis of selective removal is associated with the DNA damage recognition step.
The main difference between the TC- and GG-sub-pathways of NER is the DNA damage
recognition step: GG-NER is activated by XPC-RAD23B factors that sense the altered
helix conformation induced by DNA damage, whereas TC-NER is activated by the stalling
of RNA polymerase II (Pol II) (Hanawalt, 2002; Ljungman and Lane, 2004). Therefore,
a working hypothesis is that 3-AF-A stalls Pol II but does not induce significant helix
distortion (Otto et al., 2017). Pol II efficiently transcribes over small DNA lesions like
O6-methyl-guanine (O6-Me-G), 8-oxo-guanine (8-oxo-G), N2-1-carboxyethyl-guanine and
N3-carboxymethyl-thymine, among others (Burns et al., 2010; Tornaletti et al., 2004; You
et al., 2012, 2015), however, larger modifications can induce it to stall. Upon Pol II stalling,
downstream factors are recruited to the damage site, and the repair process then progresses
in the same manner as for GG-NER (Hanawalt, 2002; Ljungman and Lane, 2004).
The mechanism of Pol II stalling at several DNA lesions has been elucidated. Cyclobu-
tane pyrimidine dimers (CPDs), cisplatin 1,2-d(GPG) intrastrand crosslinks, monofunc-
tional pyriplatin-guanine adducts and 8,5’-cyclo-2’-deoxyadenosine strongly inhibit Pol II
progression and crystal structures of yeast Pol II bound to DNA containing these lesions
were solved to elucidate the basis of polymerase stalling or bypass (Brueckner et al., 2007;
Damsma et al., 2007; Walmacq et al., 2015; Wang et al., 2010; Shin et al., 2017, 2016).
Two flexible elements of the Pol II active site, the bridge helix and the trigger loop, are
required for nucleotide addition and nucleic acid translocation to the next template posi-
tion (Xu et al., 2014; Fouqueau et al., 2013; Brueckner et al., 2009; Da et al., 2016). Wang
and co-workers reported the blockage of Pol II by minor groove binding pyrrole-imidazole
polyamides and identified their interaction with the residues Arg1386 and His1387 in the
conserved switch 1 region of Rpb1 by molecular modelling (Xu et al., 2016). Despite these
insights, there is no direct observation of Pol II encountering a DNA template with mi-
nor groove adducts, and it is unknown how Pol II deals with minor-groove-binding and
-modifying agents.
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In this study, the question of how minor groove DNA alkylation impedes RNA syn-
thesis was addressed. Evaluating transcription activity in a human cancer cell confirmed
the inhibited RNA synthesis. Due to the chemical instability of the native AF adduct
(Gong et al., 2007; Woynarowski et al., 1997), we characterized the behavior of Pol II in
transcription over its stable analog 3-deaza-3-methoxynaphtylethyl-adenosine (3d-Napht-
A) (Figure B2b) (Malvezzi et al., 2017). We tested the capacity of 3d-Napht-A to stall
purified RNA Pol II with DNA constructs mimicking the transcription bubble and ternary
elongation complexes, and tested the limits of Pol II’s size tolerance of minor groove alkyl
adducts by carrying out the same investigation with other 3-deaza-alkyl-adenosine analogs
of systematically smaller size, i.e. 3-deaza-3-phenethyl-adenosine (3d-Phen-A) and 3-deaza-
3-methyl-adenosine (3d-Me-A) (Figure B2c). The mechanism of stalling was furthermore
investigated by crystallographic analysis of the stalled Pol II in the ternary elongation
complex (EC) with bound DNA template and RNA transcript. These data reveal a previ-
ously unobserved mode of Pol II stalling and provide insights into the chemical topology
of minor groove modifications required to stall transcription in cancer cells.
3.2.3 Pol II stalling at minor-groove alkylation adducts
We assessed the capacity of the major 3-AF DNA adduct to impede the progress of RNA Pol
II using purified yeast Pol II and DNA that contains 3d-Napht-A, a chemically stable analog
of the adduct, in constructs of a transcription bubble with 3d-Napht-A four or nine bases
downstream of the growing RNA 3’-end (Figure 21b) (Gaykalova et al., 2012). When RNA
was extended in the presence of four NTPs, Pol II stalled after nucleotide incorporation
opposite the 3d-Napht-A, whereas it transcribed efficiently over unmodified A or the smaller
methylated analog 3d-Me-A (Figure 21 b). RNA extension of a transcription bubble with
3d-Napht-A nine bases downstream of the RNA 3’-end behaved similarly (Figure 21 c,d).
3.2.4 Structural study of RNA polymerase II stalling by DNA
alkylation
To investigate the mechanism of Pol II stalling opposite an alkylated template base, we
determined the structure of a Pol II elongation complex in the presence of 3d-Napth-A. We
reconstituted a 12-subunit S. cerevisiae Poll II elongation complex (EC) with a modified
nucleic acid scaffold (Figure 22).
The resulting complex was crystallized, and the structure was determined using molec-
ular replacement. Electron density was observed for 8 bp of downstream DNA, for the
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Figure 21: a, c. DNA constructs used for testing the impact of 3d-alkyl-A analogs on
the propensity of Pol II to form run-off transcripts. DNA template (dark blue) and RNA
primer (red) were annealed, then allowed to react with Pol II (10 min at 25ÂřC). The
non-templating DNA strand (light blue) was then annealed to create the transcription
bubble. Alkylated adenine analogs were placed four nucleotides (a, b) or nine nucleotides
(c, d) downstream of the transcription start on the DNA template. b, d. Denaturing
gel electrophoresis representing Pol II transcription over A, 3d-Me-A and 3d-Napht-A in
presence of all four NTPs (1 mM). Reactions were quenched after 25 min. The site of the
modified base is indicated with an x. Experiments in a, b were performed by S. Malvezzi.
Experiments performed in c, d were performed by Lucas Farnung.
DNA template strand up to upstream position -10, and for the entire RNA except for the
5’-terminal base at the upstream end of the DNA-RNA hybrid (Figure 23).
The register of nucleic acids was unambiguously defined by bromine labelling of the
DNA template strand at position -4 and anomalous diffraction (Figure 24). The DNA
modification was clearly observed in the electron density (Figure 24). The structure was
refined to a free R factor of 22 % at a resolution of 3.2 A˚, resulting in an atomic model
with very good stereochemistry (Table B2).
The structure revealed a previously unobserved mode of Pol II interaction with a modi-
fied DNA nucleotide. The EC adopts the post-translocation state with the modified adenine
base being accommodated in the templating position opposite of the +1 site that binds the
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Template DNA Nontemplate DNA RNA
B 5-Bromouracil X 3d-Napht-A
T A C T C C B C C C X G T T C A T C A
A A G T A G T
GGGAGGAGCU
+1-1
+5 +10
Downstream duplex
5’3’
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Metal A
Bridge Helix
NTP site
5’
3’
5’
-8
U
T
C
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T TG G GA
Figure 22: The nucleic acid scaffold used in the crystal structure is depicted schematically
with respect to the +1 site containing the 3d-Napht-A base modification. The colour
scheme is used throughout the figure.
nucleoside triphosphate substrate (Figure 23). The 3-deaza-3-methoxynaphtylethyl group
contacts the central bridge helix in the Pol II active center from underneath. In particular,
the second aromatic ring of 3d-Napht-A forms van der Waals contacts with the side chain
methyl group of bridge helix residue Thr831. The trigger loop adopts an open conforma-
tion, similar to that observed in a previous EC structure that adopts the post-translocation
state (PDB 1Y1W) (Kettenberger et al., 2004).
The structure immediately suggests the mechanism of impaired Pol II progression and
stalling at an alkylated template base and explains the structure-activity profiles observed
herein. Superposition of a Pol II EC structure containing a closed trigger loop (PDB
2E2H) (Wang et al., 2006) showed that the closed state cannot be accommodated in the
presence of the alkylated nucleotide due to clashes between trigger loop residues Thr1080
and Leu1081 and the 3-deaza-3-methoxynaphtylethyl group (Figure 25). Inefficient nu-
cleotide incorporation can apparently still take place, because catalysis can occur in a
trigger loop-independent, low-fidelity fashion (Toulokhonov et al., 2007), explaining the ob-
served misincorporations. After a single (mis)incorporation event, translocation is strongly
impaired, however, as this would result in major clashes of the 3d-Napht-A moiety with
Pol II residues that very intimately interact with the minor groove of the hybrid base pair
in the post-translocation position -1. In addition, movement of the bridge helix, also re-
quired for translocation (Brueckner and Cramer, 2008), is likely impaired by the observed
alkyl-bridge helix contact.
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3d3-NAPHT-dA (+1)
NTP site
Metal A
Figure 23: Overview of the Pol II elongation complex structure with the modified adenine
present in the +1 site, the nucleotide addition site. Pol II is shown as a silver ribbon model
in a side view. The bridge helix is coloured in green. Nucleic acids are presented as stick
models. 3d-Napht-A is highlighted in orange.
3.2.5 Discussion
The stalling of isolated Pol II at 3d-Napht-A observed in this study supports the assertion
that in cells treated with AFs, transcription is stalled and the stalled Pol II initiates TC-
NER and reduces drug action. The chemical basis of this cellular process appears to be
associated with the alkyl adduct preventing translocation of the nascent +1 base pair to
the next template position due to clashes with Pol II residues binding the minor groove
edge of the DNA-RNA base pair at position -1, and by a clash of the second ring on the
methoxynaphtyl group with two residues of the mobile trigger loop (Figure 25). These
interactions highlight a different Pol II stalling mechanism than predicted by Dervan and
Wang in the case of polyamide minor-groove binding agents, wherein Pol II was stalled
upstream of the polyamide-bound DNA by interactions between the Switch 1 region and
the minor-groove binder impeding translocation (Xu et al., 2016). The structure analysis
and structure-activity relationships elucidated in the current study suggests the smaller
phenethyl group of 3d-Phen-A does not prevent the trigger loop from closing, allowing Pol
II to bypass analogs with only one aromatic ring. Finally, Pol II preferentially incorporated
UMP opposite the smaller analogs 3d-Me-A and 3d-Phen-A, and RNA could be extended.
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Br (-4)
3d3-NAPHT-dA
Metal A
+1
-1 +1
-1
Figure 24: Simulated annealing omit map after removing the 3d-Napht moiety at the +1
site from the model (Fo-FC map, contoured at 3σ, positive density is coloured in green). A
peak in the anomalous difference Fourier map (density is coloured in yellow, contoured at
6σ) reveals the exact position of the bromine atom at position -4, allowing unambiguous
assignment of the post-translocated state.
The mechanism of Pol II stalling reported herein should inform the design of improved
anticancer alkylating agents that inhibit DNA synthesis without impeding the progression
of RNA polymerase, thus evading TC-NER. Based on our results, 3-adenosine adducts with
only one ring are tolerated by Pol II but do block the replicative DNA polymerase hPol
α (Malvezzi et al., 2017). Moreover, the chemical modifications did not destabilize DNA
duplexes, suggesting that 3-AF-A adducts do not induce helix distortion and evade GG-
NER (Malvezzi et al., 2017). Thus, 3-adenosine adducts containing one phenyl ring may
have a desired balance of properties in order to inhibit DNA replication but avoid TC-NER.
The detailed insight derived from this study reveals how clashes between DNA adducts and
residues binding the DNA-RNA minor groove edge and the mobile trigger loop of RNA
Pol II prevent translocation after insertion of a nucleotide opposite an adduct. Knowledge
concerning structural characteristics that impede Pol II improves our understanding of how
cells initiate the repair of damaged DNA and may also support the design of more effective
cancer therapeutics.
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Locked (TFIIS)
Trapped
(arrested)Open Wedged
(Translocation)
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(Nucleotide
Incorporation)
Template DNA
Nontemplate DNA
RNA
Metal A
3d3-NAPHT-dA
Trigger loop
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Figure 25: Trigger loop conformations. Comparison of the conformation of the trigger
loop observed here (cyan) with alternative conformations observed previously for Pol II.
The closed trigger loop (PDB 2E2H), open trigger loop in the post-translocation state
(PDB 1Y1W), wedged trigger loop (PDB 2VUM), trapped trigger loop (PDB 3PO2),
and locked trigger loop (PDB 3PO3) are depicted in yellow, blue, red, violet, and brown,
respectively. Metal A is shown as a magenta sphere.
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The recently published cryo-EM reconstruction of the budding yeast Snf2 ATPase mo-
tor bound to a nucleosome provided the first glimpse into the mechanism of a chromatin
remodeller on its natural substrate (Liu et al., 2017). The structure confirmed a great
number of biochemical data on the proper positioning of the ATPase motor on the nu-
cleosome (Kagalwala et al., 2004; Nodelman et al., 2017). The lack of an ATP analogue,
however, prevented the authors from visualizing the engaged ATPase. Furthermore, the
authors used a truncated form of Snf2. This impeded elucidation of the exact mechanism
of chromatin remodelling and prevented the authors from understanding how regulatory
domains influence remodelling activity.
Our NCP-Chd1 structure now presents the first structure of a full-length chromatin re-
modeller bound to its natural target in the presence of a non-hydrolyzable ATP derivative.
The structure, in combination with the already available biochemical and structural data,
begins to reveal the intricate intra- and intermolecular regulatory mechanisms that control
chromatin remodellers. The use of full-length Chd1 reveals how auxiliary domains con-
trol remodelling activity. It further expands our understanding of the conserved ATPase
motor shared by SF2 family members (Wigley and Bowman, 2017); Comparison of the
apo Snf2 ATPase motor bound to the nucleosome with the ADP·BeF3 bound structure of
Chd1 reveals the pre- and post-translocated state of the ATPase motor and confirms a one-
base-pair-per-ATP DNA translocation mechanism. Ratcheting explains the translocation
movement which ultimately provides the basis for chromatin remodelling. The ATPase first
binds DNA in a partially closed conformation. Binding of ATP then leads to a full closure
of the ATPase motor, resulting in fully closed lobe 2. This is the structural rearrangement
that provides the basis for DNA translocation by a single base pair step. Hydrolysis of
ATP and dissociation of ADP and Pi resets the ATPase. In conclusion, cycles of ATP
hydrolysis lead to a movement of the ATPase motor in one direction, while shifting DNA
towards the dyad. This pulls DNA in from the opposite site and makes the DNA longer
on the proximal side where Chd1 binds, ultimately resulting in chromatin remodeling. On
this basis, a full picture for a mechanism of chromatin remodelling starts to emerge that
has a broad foundation in biochemical data and structural observations (Figure 26) (Hauk
et al., 2010; Nodelman et al., 2017; Sundaramoorthy et al., 2017).
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Figure 26: Schematic for a model of the mechanism of chromatin remodelling by Chd1.
4.1 Towards a model for chromatin remodelling
To further elucidate the mechanism of chromatin remodelling, it is necessary to establish
the full enzymatic cycle of a single remodeller in the presence of its substrate. So far, two
structures of chromatin remodellers bound to the nucleosome have been published/are in
press. However, the two structures have trapped the chromatin remodeller in two different
states. Snf2 was trapped in a partially closed state with no ATP present (Liu et al., 2017),
while Chd1 presented in this study was trapped in a closed, post-translocated state in
the presence of the transition state mimicking adduct ADP·BeF3. To allow for precise
understanding of the remodelling mechanism, additional structures of the same remodeller
should be solved in the presence of other ATP analogues or ADP. Chd1 seems to be an
appropriate target because it allows for study of the ATPase motor as wells as its auxiliary
domains. Most chromatin remodellers are components of larger assemblies, where other
polypeptides in the complex carry the regulatory functions found in the auxiliary domains
of Chd1 (Clapier et al., 2017). To allow proper comparison between the Snf2 structure and
our structure, it is important to capture Chd1 bound to a nucleosome in the absence of
nucleotide. This would allow for comparison of the translocation state and confirm that
the structural rearrangements observed in our structure are a result of the presence of
nucleotide.
Chromatin remodellers translocate DNA, hence DNA distortion is expected to occur
during the process of remodelling. To capture these distortions it is necessary to obtain
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structures at even higher resolutions. Higher resolutions could be obtained by use of a
phase plate (Chua et al., 2016), collection at higher magnifications or greater particle
number. Perhaps these approaches also require time-sensitive sample preparations where
ATP is added to the complex for a short period of time before freezing the sample to
trap Chd1 while it is actively remodelling the nucleosome. Such a time-sensitive approach
would also require extensive data collection followed by thorough data analysis with a
strong emphasis on classifying the captured states to obtain homogenous states at high
enough resolutions to shed light on the intricate mechanism of ATPase motor movement
and DNA translocation.
Higher resolution reconstructions should also further elucidate the interactions of the
chromatin remodellers with the histone octamer. The H4 tail appears to be an important
hub for interactions of ATPase lobe 2 with the histone octamer. Additionally, interactions
have been also observed with H3. The human CHD1 is able to interact with modified
tails of H3 (Sims et al., 2005). There is strong biochemical evidence that the chromatin
remodeller auxiliary domains associate with the acidic patch of H2A/H2B, however, this
interaction has not been observed in any presently available chromatin remodeller structure
(Leonard and Narlikar, 2015; Dann et al., 2017).
4.2 Increasing complexity: chromatin biology and tran-
scription
With recent advances in recombinant protein expression and cryo-EM, it is possible to
target larger complex assemblies for structural characterization at resolutions well below
ten A˚ngstro¨ms (Vos et al., 2016; Scheres, 2012). Formation of well-defined complexes,
which have characteristics favorable for cryo conditions, appears to be the most substantial
challenge in visualizing such complexes. Preparation techniques such as GraFix or size
exclusion chromatography have proven to be amenable for complex formation (Kastner
et al., 2008; Martinez-Rucobo et al., 2015). Complexes can be further stabilized by addition
of crosslinkers, specific post translational modifications, additional binding factors, and
through use of specific grid chemistries for freezing (Russo and Passmore, 2014). Thus
far, each structure that has been successfully obtained by cryo-EM has required different
biochemical approaches to stabilize the components.
Studies of RNA polymerase II in its initiation and elongation context have proven
to be feasible subject of single particle analysis (Plaschka et al., 2016; He et al., 2016;
Bernecky et al., 2017). The cryo-EM reconstruction shown here illustrates that nucleosome-
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based complexes are also favorable targets. Indeed, nucleosome complexes are significantly
easier to study using cryo-EM than crystallography. However, domains and subcomplexes
obtained by crystallographic methods are required for the interpretation of cryo-EM maps,
and efforts to obtain such structures should not be reduced.
With the broad evidence suggesting a direct physical interaction between Chd1 and
transcription elongation-related factors such as Paf1C and FACT that can also bind Chd1
and the nucleosome, it is now appropriate to focus research on obtaining a stable complex
with Pol II, related elongation factors, Chd1, and the nucleosome. An initial approach
where the nucleosome is bound to the elongation machinery in trans could provide the
first insights and provide a blueprint for designing a nucleosomal scaffold that can bind
Pol II in cis. Ultimately, a RNA polymerase II-nucleosome core particle complex should
elucidate how eukaryotic RNA polymerases are able to transcribe through chromatin and
unify structural studies of chromatin biology and transcription.
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A.1 Supplementary Table
Table A1: Cryo-EM data collection, refinement, and validation statistics
Nucleosome-Chd1
structure (EMDB-
3765) (PDB 5O9G)
Data collection and processing
Microscope FEI Titan Krios
Detector Gatan K2 Summit
Magnification 105,000×
Voltage (kV) 300
Electron exposure (e-/A˚2) 30
Defocus range (µm) 1.25 to 2.75
Pixel size (A˚) 1.35
Symmetry imposed C1
Initial particle images (no.) 990,020
Final particle images (no.) 67,032
Map resolution (A˚) 4.8
FSC threshold (A˚) 0.143
Refinement
Initial models used (PDB code) 3LZ0, 3MWY, 3TED
Map sharpening B factor (A˚2) -204
Model composition
Non-hydrogen atoms 19,667
Protein residues 1934
Ligands 2
Validation
MolProbity Score 1.93
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Clashscore 7
Poor rotamers (%) 0.36
Ramachandran plot
Favored (%) 90.81
Allowed (%) 9.06
Disallowed (%) 0.13
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A.2 Supplementary Figures
b c
10 nm
100 nm
Chd1
Paf1
H2A/H2B
H3H4
Spt16
Pob3
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Cdc73
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Rtf1
a
Figure A1: Complex formation and data quality. a. Formation of the nucleosome-Chd1-
FACT-Paf1C complex. SDS-PAGE of peak fraction used for cryo-EM grid preparation
containing Chd1, FACT subunits, Paf1C subunits and histones. Identity of the bands
was confirmed by mass spectrometry. For gel source data, see Supplementary Figure 1.
b. Representative cryo-EM micrograph of data collection. c. 2D class averages contain
nucleosome-like shapes.
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Figure A2: Overall fit of the nucleosome-Chd1 structure. Two views are depicted as in
Fig. 7b, c.
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Figure A3: Quality of the nucleosome-Chd1 structure. a-e. Electron density (grey mesh)
for various Chd1 domains reveals secondary structure and a good fit for DNA (SHL -4 to
SHL +7). f. Superposition of the histone octamer core with canonical octamer core (PDB
code 3LZ0). The canonical octamer core is rendered in grey.
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Figure A4: Nucleosome-Chd1 reconstruction colored according to local resolution.
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Figure A5: Angular distribution of particles. Red dots indicate the presence of at least
one particle image assigned within ± 1°. Shading from white to black indicates the density
of particle images at a given orientation.
69
A. Appendix: Nucleosome-Chd1 structure
0.0 0.1 0.2 0.3
0.0
0.2
0.4
0.6
0.8
1.0
0.143
0.5
4.8 Å
6.9 Å
NCP-Chd1 half maps
NCP-Chd1 model vs map
Resolution [1/Å]
FS
C
ATPase motor vs map (masked)
Double Chromodomain vs map (masked)
DNA-binding region vs map (masked)
Figure A6: Estimation of the average resolution. The dark blue line indicates the Fourier
shell correlation between the half maps of the reconstruction. The dotted light blue line
indicates the Fourier shell correlation between the derived model and the reconstruction.
Resolutions are given for the FSC 0.143 and the FSC 0.5 criterion. The dotted lines show
the Fourier shell correlation between the derived Chd1 domains and the corresponding
masked regions.
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II stalling by DNA alkylation
Stefano Malvezzi*, Lucas Farnung*, Claudia Aloisi, Todor Angelov, Patrick Cramer,
Shana J. Sturla. (2017) Mechanism of RNA polymerase II stalling by DNA alkylation
PNAS. (accepted in principle)
The additional text and figures presented in this section are based on the cited pulication.
The figures and text are included to provide additional background on the experiments
presented in the Results & Discussion section.
B.1 Supplementary text
B.1.1 DNA alkylation impairs RNA synthesis in cells
It has been established that cells proficient in TC-NER are more resistant to cytotoxicity
induced by AFs (Jaspers et al., 2002; Koeppel et al., 2004; Otto et al., 2017). To evaluate,
therefore, how AF impacts RNA synthesis in cancer cells relative to a simple methylating
agent, we compared RNA synthesis activity following treatment with HMAF vs. MMS.
MMS can form various DNA methylation adducts, mainly the non-cytotoxic 7-Me-G, but
also 3-Me-A, and to a lesser extent O6-Me-G (Beranek, 1990; Brink et al., 2007). A sig-
nificant reduction of RNA synthesis in colon adenocarcinoma SW480 cells overexpressing
PTGR1 (SW480-PTGR1), an enzyme required for metabolic bioactivation of AFs, was ob-
served after treatment with 1 µM HMAF, but not 1 µM MMS (Figure B6), concentrations
at which all cells remained viable (Figure B5). Because MMS is much less potent than
HMAF, we also evaluated RNA synthesis at doses that reduce cell viability equally with
both compounds (Figure B7b). Again, RNA synthesis was significantly reduced in cells
treated with 0.5 µM HMAF, but not in cells treated with 500 µM MMS. These results
provide evidence for Pol II stalling after minor groove DNA alkylation in cancer cells.
71
B. Appendix: Mechanism of RNA polymerase II stalling by DNA alkylation
B.1.2 Pol II transcription can stall at minor-groove alkylation
adducts
We next characterized RNA extension with ternary elongation complexes composed of an
RNA annealed to a DNA template containing the analog at the nucleotide incorporation
site +1 (Figure B3a). In the presence of all four NMPs, Pol II stalled at 3d-Napht-A after
incorporating one NMP (Figure B3b) and no bypass was observed even after 60 min. When
the same reactions were carried out with individual nucleotides, Pol II incorporated UMP
and misincorporated CMP opposite 3d-Napht-A but not GMP and AMP (Figure B7c).
B.1.3 Pol II is tolerant to smaller modifications but errors arise
To derive the maximum adduct size tolerated by Pol II, RNA extension was evaluated
for templates containing smaller alkyl groups. Pol II efficiently extended RNA annealed
with templates containing A or 3d-Me-A, forming full-length products (Figure B7b). 3d-
Phen-A was bypassed, but product accumulated after incorporation of the first nucleotide,
suggesting the intermediate size adduct slows Pol II but does not impede it completely.
In the presence of individual nucleotides, UMP was very efficiently incorporated, lead-
ing to a +2 band resulting from insertion of UMP opposite A plus the next G. For modified
substrates with 3d-Me-A or 3d-Phen-A, however, only the +1 band was observed for UMP,
suggesting that the 3-alkyl groups reduced transcription fidelity. A similar degree of CMP
misincorporation was observed in all cases, regardless of the DNA being modified or not
(Figure B8). Moreover, Pol II efficiently misincorporated CMP opposite the next templat-
ing G forming a +2 band product, whereas in the case of 3d-Napht-A, only one nucleotide
was inserted opposite the analog.
B.1.4 DNA alkylation alters Pol II incorporation and extension
efficiency
Having established that Pol II incorporates UMP and CMP to varying extents depend-
ing on the identity of DNA modification, we measured apparent reaction rates for their
incorporation by Pol II (Figure B4). For insertion of UTP opposite A or 3d-Me-A, incor-
poration rates were similar (9.0 ± 1.4 min-1 and 8.0 ± 1.2 min-1 respectively), whereas
rates opposite 3d-Phen-A and 3d-Napht-A were significantly reduced (2.5 ± 0.2 min-1 and
1.2 ± 0.2 min-1, respectively). The CMP misincorporation profile was quite different, how-
ever, with more than 10-fold greater incorporation opposite 3d-Me-A vs. A (5.8 ± 0.4
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min-1 vs. 0.5 ± 0.1 min-1, whereas 3d-Phen-A and 3d-Napht-A were similarly low as A
(0.28 ± 0.03 min-1 and 0.39 ± 0.05 min-1) (Figure B4a). The increased misincorporation
of CMP opposite the 3-alkyl-adenosine analogs relative to A (Figure B4a) suggests a po-
tential basis of transcriptional mutagenesis (TM) in cells (You et al., 2012; Burns et al.,
2010). To understand the impact of 3-deaza-3-alkyl-adenosine analogs on Pol II activity
during the extension steps following incorporation opposite an adduct, we evaluated RNA
synthesis using DNA constructs with the RNA transcript containing either U or C opposite
3-deaza-3-alkyl-adenosine analogs and measured rates of CMP incorporation opposite the
next templating G (Figure B4b). Extension after 3d-Me-A was similar to after A, but
after 3d-Phen-A, extension from U or C was 170- or 250-fold lower, respectively, and after
3d-Napht-A, extension by Pol II was totally blocked, with no incorporation even after 60
min. This observation was consistent with the initially observed stalling after insertion of
one nucleotide opposite the modified base. From these data, it could be concluded that Pol
II is stalled by the larger analog 3d-Napht-A, whereas it bypasses smaller analogs with the
efficiency decreasing in step with the size of the 3-alkyl group size. The efficient bypass of
3d-Me-A was consistent with the observation that exposing cells to MMS did not reduce
transcription.
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B.2 Supplementary table
Table B2: X-ray data collection and refinement statistics. Values in parentheses are for
the highest-resolution shell.
EC I with 3-deaza-3-
methoxynaphtylethyl
group
EC II with 3-deaza-3-
methoxynaphtylethyl
group - Bromine peak
Data collection
Space group C2221 C2221
Cell dimensions
a, b, c A˚ 221.4, 394.9, 283.7 220.4, 394.2, 283.5
α, β, γ (°) 90, 90, 90 90, 90, 90
Resolution (A˚) 49.88 - 3.2 (3.31 -3.2 49.7 - 3.61 (3.73-3.61
Rmerge 0.137 (2.29) 0.403 (2.103)
Rmeas 0.142 (2.38) 0.41 (2.18)
I/σ(I ) 16.4 (1.4) 12.9 (1.5)
CC1/2 0.999 (0.53) 0.992 (0.711)
Completeness (%) 100 (100) 100 (100)
Redundancy 13.5 (13.3) 38.9 (14.2)
Refinement
Resolution (A˚) 49.88 - 3.2 (3.51 - 3.2)
No. reflections 202,994 (20,129)
Rwork/Rfree 0.18 (0.33) 0.22 (0.36)
No. atoms 31,670
Protein/DNA 31,626
Ligand/Ion 44
B factors (A˚2)
Protein 139.6
Ligand/Ion 140.8
R.m.s. deviations
Bond lengths (A˚) 0.033
Bond lengths (°) 1.03
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B.3 Supplementary figures
Figure B2: Mechanism of minor groove DNA adduct formation from acylfulvenes and
structures of the minor groove adduct models used in this study. a. Acylfulvenes are bioac-
tivated in the cytosol by the reductase PTGR1 to form a reactive intermediate that prefer-
entially alkylates position 3 of adenine in genomic DNA. The cytotoxicity of acylfulvenes is
dependent on the DNA repair proficiency of exposed cells, with cells deficient in TC-NER
being more susceptible than cells proficient in TC-NER. b. Structure of the 3-deaza-3-
methoxynaphtylethyl-adenosine analog (3d-Napht-A) incorporated in oligonucleotides and
used as model of acylfulvene-derived DNA adducts in biochemical and crystallographic
studies. c. Structure of 3-deaza-adenosine analogs of decreasing size, 3-deaza-3-phenethyl-
adenosine (3d-Phen-A) and 3-deaza-3-methyl-adenosine (3-Me-A) used to enable structure-
activity analysis of Pol II.
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Figure B3: Pol II full-length synthesis and single nucleotide incorporation. a. Ternary
elongation complexes containing A, 3d-Me-A, 3d-Phen-A or 3d-Napht-A at the underlined
position, used for primer extension reactions. DNA template is dark blue, non-template
DNA is light blue, RNA primer is red. b. Denaturing gel electrophoresis of Pol II tran-
scription products in the presence of all four NTPs (1mM). Extension of the RNA primer
to the end of the DNA template forms the indicated run-off product (+14). c. Single nu-
cleotide incorporation opposite A, 3d-Me-A, 3d-Phen-A and 3d-Napht-A. Reactions were
performed in presence of a single NTP (1mM) and were quenched after 20 min.
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Figure B4: Single nucleotide incorporation and extension kinetics. a. Gel denaturing
electrophoresis of primer extension kinetics by Pol II for UMP and CMP incorporation
opposite unmodified adenine or 3-deaza-adenosine analogs (left). Reactions contained 1
mM NTP and were stopped at various time points between 0 and 60 min. Schematic rep-
resentation of apparent rate constants for UMP and CMP incorporation kinetics (right).
Error bars represent standard deviation (N=3) and statistical significance for NMP incor-
poration opposite the 3-deaza-3-alkyl-adenosine adducts compared to A was determined
by unpaired Student t-test with Welch’s correction (*p < 0.05, ** p < 0.01). b. Rates
(min-1) of RNA primer extension from the correct base pair Aanalog:U (left) and the mis-
matched base pair Aanalog:C (right). The DNA template contained either A, 3d-Me-A,
3d-Phen-A or 3d-Napht-A at the indicated position. RNA yield is plotted as a function
of time (100 % RNA yield corresponds to 50 % of primer extension). Error bars represent
standard deviation (N=3).
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Figure B5: Levels of RNA synthesis in SW480-PTGR1 cells treated with HMAF and
MMS. RNA synthesis was quantified on the basis of emitted fluorescence indicating in-
corporation of 5-ethynyl uridine in RNA during transcription, followed by coupling with
the fluorescent azide dye Alexa488. Fluorescence signal was normalized to the signal from
untreated cells. Error bars represent standard deviation (N≥8). Statistical significance
of treated cells compared to untreated cells was determined by one-way ANOVA with
Dunnett post hot test (*p < 0.0001).
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Figure B6: DAPI fluorescence signal in SW480-PTGR1 cells after 6 h of exposure to
HMAF (0.5 and 1 µM) or MMS (500 and 1 µM). The average of fluorescence is represented
with standard deviation (N=3).
Figure B7: Cell viability of SW480-PTGR1 cells after 6 h of exposure to increasing
concentration of HMAF (0-1000 nM) or MMS (0-1000 µM) and 24 of post-incubation.
Cell viability was determined with the CellTiter Glow assay. Average of cell viability is
represented with standard deviation (N=3).
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Figure B8: Quantification of single nucleotide incorporation opposite the 3-alkyl adeno-
sine analogs. Reactions were performed in presence of a single NTP (1 mM) and were
quenched after 20 min. The average of RNA yield is represented with standard deviation
(N=2).
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